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Protein kinase R (PKR) is a key component of the interferon-induced immune 
response to viral stress.  It contains two N-terminal dsRNA binding domains (dsRBD) 
and a C-terminal serine/threonine kinase domain separated by a 90 residue 
unstructured linker of unknown function.  PKR is activated by viral dsRNAs via 
dimerization and autophosphorylation of specific serine and threonine residues. We 
have developed an assay to measure dimerization of PKR while bound to various 
dsRNAs using Fӧrster resonance energy transfer. This is the first direct measurement of 
PKR dimerization upon dsRNAs binding. Our results show that inactive dimers of PKR 
exist in solution, and that a specific back-to-back dimer configuration is essential for 
activation. The role of the interdomain linker was determined by characterizing linker-
deleted constructs of PKR. We propose that the unstructured linker may exist to 
negatively regulate PKR activation by limiting it’s binding stoichiometry and curbing 
dsRNA-independent activation. The role of the second dsRNA binding domain was 
probed by mutating residues likely to contact dsRNA. Collectively, the studies presented 
here provide new insight on the elusive mechanism of dsRNA induced PKR activation. 
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1.1 Role of PKR in immune response and signaling 
Protein kinase R is a critical component of the innate immune response to a variety of 
stress stimuli such as viral infection1. It exists endogenously in host cells in a latent 
inactive state and is over-expressed upon induction by type I interferon2.  PKR contains 
tandem N-terminal dsRNA binding domains separated by a 20-residue linker and a C-
terminal kinase domain. The kinase and dsRNA binding domains are separated by a 
long unstructured linker of ~90 residues in length. PKR recognizes and binds to viral 
RNAs that are generated in the cell as a by-product of viral replication3,4, and becomes 
activated via dimerization and autophosphorylation5. Activated PKR phosphorylates 
eIF2α, which impairs the initiation of translation of host and viral proteins in the cell6. 
eIF2A is a heterotrimeric complex comprising of α, β and γ subunits. In the GTP bound 
form and in the presence of eIF2B it is able to bind to the initiating Met-tRNA and can 
transfer the tRNA to the 40S ribosome to initiate protein translation via GTP-GDP 
exchange7. Phosphorylation of eIF2α at S51 locks the subunit in a GDP-bound state 
incapable of binding to the Met-tRNA and initiating protein translation. Consequently the 
translational machinery is unable to synthesize viral and host proteins eventually 
leading to apoptosis, thus containing the spread of the infection. In addition to the eIF2α 
phosphorylation, PKR participates in a myriad of cellular signaling pathways, which 
relate to cell proliferation, tumor suppression, and activation of transcription factors such 
as interferon8. In the absence of stimulus the transcription factor NFκB is sequestered in 
the cytosol by two inhibitory proteins IκBα and IκBβ in the cytosol9. The binding of these 
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proteins block the nuclear localization sequence as well as the DNA binding region of 
NFκB thus inhibiting its ability to serve as a transcriptional regulator. Phosphorylation 
the of the IκB proteins at specific serine and threonine positions lead to the dissociation 
from NFκB and they are then tagged for proteasomal degradation via polyubiquitnation. 
IκB phosphorylation is mediated by IKK (IκB kinases), which is a substrate of active 
PKR. Phosphorylated PKR activates IKK and mediates the release of NFκB, which can 
transcriptionally regulate various genes involved in immunity, inflammation, cell 
proliferation and differentiation among many10. 
1.2. Mechanism of PKR activation by dsRNA 
PKR binds to dsRNA in a sequence non-specific manner and binds most strongly to 
perfect duplexes3. The dsRNA binding domains of PKR are members of a large family 
of homologous domains, including Xlrbpa2 from Xenopus laevis. The crystal structure of 
Xlrbpa2 in complex with 16 bp duplex show that the intermolecular interactions are 
primarily between positively charged residues on the dsRBD and backbone 
phosphodiester oxygen and 2’-OH groups on the dsRNA. Xlrbpa2, which is a single 
dsRBD, makes contacts within two minor grooves and the adjoining major groove and 
has a footprint of 16 bp11.  PKR contains two such dsRBDs. PKR is activated by 
dsRNAs in a length dependent manner. The shortest dsRNA that can activate PKR is 
30 bp12,13. Activation follows a “bell-shaped” pattern as a function of dsRNA 
concentration due to the inhibition of PKR activation at high dsRNA concentrations14,15.  
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Mechanism of PKR activation by variable length duplex RNAs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PKR is a member of the host anti-viral interferon induced defense pathway and is 
activated upon binding to viral dsRNA containing complex secondary structural 
features16. PKR consists of a C-terminal kinase domain and an N-terminal dsRBD 
separated by a 90 residue unstructured linker (Figure 1.1.). The N terminal lobe of the 
kinase is involved in forming the dimer interface and the C terminal lobe contains the 
substrate recognition site for eIF2α17. The nucleotide-binding site is located in between 
the two lobes. The dsRBD consists of tandem dsRNA binding motifs (dsRBM) 1 and 2, 
each having the conserved αβββα fold separated by a short linker18. The structures of 
the kinase domain17 and dsRBD18 have been solved by X-ray crystallography and NMR, 
respectively. No structure of full length PKR is available.  
  
Fig. 1.1. Domain organization of PKR.   
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PKR is biased to binding A-form dsRNA19. Studies performed previously have revealed 
that the 30 bp duplex is the minimum length dsRNA that can activate PKR (Figure 2). It 
is also the minimum length required for the binding of two PKR monomers13. These 
results led to the proposal of the dimerization model for PKR activation by duplex RNAs 
in which the role of the dsRNA is to bind two PKR monomers, leading to dimerization 
and activation.   
The effect of salt concentration on the stoichiometry and binding affinity of PKR to 
dsRNA has been studied previously13. It was observed that a decrease in the NaCl 
concentration from 200 mM to 75 mM leads to a considerable increase in binding affinity 
as determined by sedimentation velocity and fluorescence anisotropy experiments.  
 Constructs of the dsRBM1 alone and the dsRBD have been studied for their 
interaction with variable length duplex RNAs20. The stoichiometry with which the 
dsRBM1 binds dsRNA increases sequentially with RNA length as a result of the 
P P 
eIF2α 
eIF2α P 
Viral and Host 
Protein 
Synthesis 
Inactive Active 
Dimeriza(on+model+for+ac(va(on+
Fig. 1.2. Dimerization model for PKR activation by dsRNAs ≥ 30 bp.  
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increase in number of available configurations.  However, the dsRBD consisting of both 
motifs does not display the same trend.  The stoichiometry of binding increases 
systematically from 15-35 bp, and then decreases with dsRNAs longer than 35 bp. This 
indicates a greater site size on longer activating duplexes relative to shorter non-
activating sequences. 1H-15N HSQC NMR spectra of the dsRBD have been examined 
upon titration with 20 bp and 40 bp dsRNAs. The resonances most affected upon 20 bp 
interactions correspond to regions in the dsRBM1 and the N-terminus of the dsRBM2. 
However upon 40 bp titration residues corresponding to both the dsRNA binding motifs 
showed significant chemical shifts, indicating that the dsRBM2 makes additional 
interactions with longer, activating dsRNAs. 
1.3. RNAs that interact with PKR in vivo 
Several viral and cellular RNAs have been found to activate PKR. The internal ribosome 
entry site (IRES) RNA produced by the Hepatitis C virus consists of several domains 
with complex secondary structural elements such as internal loops, bulges and a 
pseudoknot21,22. At least one of the domains has been found to activate PKR through a 
partial structural mimicry of A-form dsRNA. The 3’-UTR of tumor necrosis factor – α 
(TNF- α) mRNA has also been found to activate PKR indicating that cellular regulation 
of PKR also occurs23. Several viruses have developed mechanisms to block the 
activation of PKR and its downstream signaling processes. Adenovirus and Epstein Barr 
virus (EBV) produce inhibitory RNAs that abrogate PKR dimerization and activation24,25. 
Adenovirus VAI consists of three domains: an apical stem, a central domain and a 
terminal stem.  VAI as well as the mutant of VAI lacking the terminal stem inhibit PKR 
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activation to the same extent. Interestingly it was shown that the apical stem and central 
domains of PKR together form a site for the binding of a single PKR molecule26,27.  
One of the most well studied dsRNAs that interact with PKR is the human 
immunodeficiency virus type - 1 transactivation-responsive region (TAR) RNA28-30.  It is 
a 23 bp stem loop RNA with three bulges that is known to dimerize. The TAR dimer 
consists of a 46 bp duplex region with an internal loop. Monomeric TAR is an inhibitor of 
PKR, whereas the TAR dimer is known to activate PKR (Figure 3). Sedimentation 
velocity studies reveal that the TAR dimer is capable of binding two monomers of PKR 
thereby allowing PKR dimerization and activation. This is also indicative of PKR’s ability 
to accommodate internal loops or barriers to dimerization.   	  
 
 
 
 
 
  
 
 
1.4.Correlation between dimerization and autophosphorylation 
The mechanism for dsRNA-induced PKR activation involves the formation a specific 
back-to-back dimer interface that was observed in the crystal structures of the kinase 
Fig. 1.3.Mechanism of activation of PKR by TAR RNA dimer. 
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domains bound to eIF2α17. PKR dimerizes weakly in the solution and can be activated 
in the absence of dsRNA31. Activation results in the autophosphorylation of specific 
serine and threonine residues within the kinase32,33. T446 in the activation segment is 
critical for the active enzyme and K296 is essential for phosphotransfer near the ATP 
binding site.    The kinase domain of PKR (258-551) has a canonical bilobal 
architecture. The N-lobe comprises of a five-stranded antiparallel β sheet and two 
helices α0 and αC. The residues that form the dimer interface reside exclusively within 
the N-lobe, many of which are in the helix αC. The C-lobe is larger containing eight α 
helices and two β strands. The N-terminal region of the helix αG in the C-lobe as well as 
residues within the activation segment make specific contacts with PKR’s substrate 
eIF2α. The ATP binding site exists in the cleft between the two lobes. K296-E308 ion 
pair in the active site aid in coordinating the nucleotide moiety and for phosphotranfer. 
K296R mutants are catalytically inactive but are still able to bind nucleotides. Threonine 
446 within the activation segment of the kinase domain dimers are phosphorylated in 
the structure. K304 and R307 side chains protruding from the helix αC and R416 from 
the C lobe coordinate phosphorylated T446. Therefore, the specific configuration of 
helix αC may be critical for facilitating the formation of the active enzyme. Mutational 
analysis of residues within the dimer interface perturbed and in some cases abolished 
PKR activation. The dimer interface is held together by a number of residues specifically 
a salt bridge R262-D266 and a hydrogen bonding interaction between Y323-D289-
Y293. In addition I288 interacts with hydrophobic interaction with a large buried surface 
area contributing significantly to dimer interface. The back-to-back dimer involves 
several residues within the helix αC. In addition, the other end of the helix αC contains 
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residues that co-ordinate the T446 within the active cleft. Therefore, there exists an 
allosteric link between the formation of the dimer interface and the activation of PKR.  
PKR is capable of dimerization in the absence of dsRNA and the Kd for self-associated 
was measured previously to be 500 µM31. Upon phosphorylation the affinity for 
dimerization increased by 1000 fold to ~ 500 nM.  	  
	  
 
 
 
 
 
 
 
 
αC 
N lobe 
C lobe 
R307 
K304 
pT446 
E308 
K296 
AMP-PNP 
αC 
a) b) 
Figure 1.4. Allosteric linkage between dimerization and activation a) Back-to-back dimer of 
kinase b) Active site of kinase with AMP-PNP  
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1.5. Unstructured regions within PKR 	  
	  
 
 
Four of fifteen phosphorylation sites exist within the N-terminal region including 
threonine and serine residues in the linker region.  One of the sites (S33) is located 
within dsRBD1 and may make contacts with dsRNA when bound. When PKR is 
autophosphorylated it has an enhanced affinity for dimerization and a reduced affinity 
for dsRNA. Therefore even a small amount of dsRNA can be recycled to initiate the 
activation of several PKR molecules. It is suggested that phosphorylation at S33 
reduces the affinity for dsRNA and therefore is a critical site in the context of the 
autocatalytic cascade. The kinase domain is separated from the N-terminal region by a 
long unstructured linker. The linker contains only one phosphorylation site (S242) and 
alanine substitution at this site causes a slight attenuation of PKR activation potency but 
does not block activation33. The linker can be divided into two sections based on 
sequence homology and amino acid content. The region 169-229 is abundant in polar 
uncharged residues, which is a signature of disordered proteins. It is also interspersed 
with negatively charged residues (Figure 1.5.)33. The length of this sequence is variable 
across different homologs of PKR and is virtually absent in PKR from Mesocricetus 
auratus or golden Syrian hamster. The C-terminal region 229-258 is enriched in basic 
residues and may possess some α helical content as predicted by secondary structure 
Figure 1.5. Inter-domain linkers of PKR.  
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prediction algorithms. It is also relatively more conserved and contains the 
phosphorylation site at 242.  
The 90 residue linker region between the dsRBD and the kinase domain of PKR 
is unstructured and is considered as an intrinsically disordered region based on full 
length PKR structural studies using SAXS34 and NMR35. SAXS data obtained for PKR fit 
best to a model where the protein exists in an ensemble of open and closed states 
based on the end-to-end distance distributions.  NMR studies with full length PKR have 
also shown that residues within the linker produce spectra that are characteristic of 
disordered proteins. There is some evidence to suggest that the linker may be involved 
in dsRNA independent activation associated with dimerization. Constructs of the kinase 
domain with the linker (169-551) were able to autophosphorylate at high concentrations 
while constructs of the isolated kinase domain (252-551) were unable to become 
activated at the same concentration range35.   
 
  
1.6 Objectives and goals 
PKR is activated upon binding dsRNA by dimerization and autophosphorylation.  The 
precise mechanism by which RNA binding stimulates activation is not clear. The active 
kinase forms a back-to-back dimer where the active sites are on opposite ends of the 
dimer. It is unclear how the autocatalytic pathway proceeds given the dimer 
Fig. 1.6. Sequence alignment of the linker from eukaryotic homologs of PKR. 	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configuration. It was previously assumed that dsRNAs that were long enough to 
assemble more than one PKR monomer were activators. However certain RNAs can 
bind two PKRs without activating. It is difficult to test if activation is blocked by an 
inability to dimerize or by some other factor.  Viral dsRNAs that interact with PKR in vivo 
possess relatively short duplex regions interrupted by complex secondary structural 
elements such as stem loops, internal loops and bulges. The mechanism by which PKR 
is able to interact across these RNA barriers and dimerize is unclear. The current 
methods available allow us to measure PKR assembly on dsRNA as well as activation. 
However, we cannot measure the interaction between adjacent kinases on a dsRNA. 
Formulating a protocol to measure PKR dimerization would allow us to confirm the 
dimerization model and to determine if dimerization is the only pre-requisite for 
activation.  
1. Define the modes of PKR binding to variable length duplex RNAs. 
Activation of PKR by longer dsRNAs is correlated with the interaction of the second 
dsRNA binding motif (dsRBM).  Mutants of PKR that lack the ability of the dsRBM2 to 
bind dsRNA will be synthesized to investigate the role of this motif. The ability of the 
mutants to bind to variable length dsRNAs will be determined using analytical 
ultracentrifugation and PKR activation will be measured by autophosphorylation assays. 
2. Investigate the effect of RNA barriers on PKR dimerization and activation. 
RNA chimeras will be designed to contain two duplex PKR binding sites separated by 
variable length inert barriers such as 2’-O-methyl modified RNA. They will be used as 
molecular rulers to determine minimum barrier distance across which PKR can activate. 
The stoichiometry and affinity of PKR binding and PKR activation will be measured 
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using the techniques mentioned in Aim 1. The effect of other RNA barriers such as 
internal loops and mismatched pairs will also be determined. 
3. Define the role of the unstructured linker in PKR dimerization. 
The 90 residue linker may be involved in enabling the kinase domains to dimerize over 
barriers in dsRNAs such as internal loops and bulges. The ortholog of PKR from 
Mesocricetus auratus (golden Syrian hamster) has a much shorter linker of about 20 
residues. Hamster PKR will be expressed and purified and its ability to interact with 
various length duplexes. In addition, linker-deleted constructs of human PKR will be 
characterized to test the effect of linker length on PKR activation. SAXS STUFF 
4. Measure functional PKR dimerization using Förster resonance energy transfer 
(FRET)  
Some dsRNAs are able to bind two PKR monomers but are incapable of activating PKR. We will 
directly assay dimerization of the kinase domain upon binding to activating and non-activating 
RNAs to determine whether dimerization is correlated with PKR activation. Fluorescent probes 
will be incorporated at specific sites near the PKR dimer interface by unnatural amino acid 
mutagenesis. FRET will be used to assay PKR kinase domain dimerization upon binding to 
RNAs. These studies will include the RNA chimeras and short duplexes mentioned in Aims 1 
and 2. 
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Chapter 2: Materials and Methods 
 
2.1. Reagents, buffers and glassware 
The buffer components and solvents used in the experiments were high purity reagent 
grade chemicals. Buffers were filtered using 0.22 µm membranes and autoclaved. 
TCEP was added to buffers immediately prior to use. Analytical ultracentrifugation cell 
components were sonicated and treated with RNAaseZap (ThermoFischer Scientific). 
Oligonucleotides used in the study were purchased from Dharmacon (Lafayette, CO). 
Fluorescent dsRNA 
 
 
TS40F - 5’-Fl GGAGAACUUCAUGCCCUUCG GAUAA GGACU CGUAU GUACC-3’ 
BS40 - 3’-      CCUCUUGAAGUACGGGAAGC CUAUU CCUGA GCAUA CAUGG-5’ 
 
Duplex dsRNA 
 
 
 
TS40B - 5’- GGAGGAUGUUAAUUGGCGUG UCUUG UCUGC AACGG UAUUC - 3' 
 
BS40B  - 3’- CCUCCUACAAUUAACCGCAC   AGAAC  AGACG UUGCC AUAAG - 5’  
 
2’-O-Methyl dsRNA 
 
 
5’ - GGAGGAUGUUAAUUG mGmCmGmUmG mUmCmUmUmG mUmGmUmCmA 
UCUGCAACGGUAUUC - 3’ 
20 25 30 35 40 
20 25 30 35 40 
5Me 10Me 15Me 
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Table 2.1. RNA sequences  
 
RNA Molecular weight (g/moles) 
Mass extinction coefficient * 
(L/g*cm) 
Fl20 bp 13062.1 4.78E6 
Fl25 bp 16477.1 2.53E6 
Fl30 bp 19699.0 3.39E6 
Fl35 bp 22905.0 3.49E6 
Fl40 bp 27655.1 2.49E6 
20B bp 13793.0 22.31  
30B bp 19142.0 24.66 
40B bp 25718.8 23.86 
15-5Me-15 22509.0 23.75 
15-10Me-15 25855.2 21.24 
15-15Me-15 29201.5 27.5 
 
*𝐌𝐚𝐬𝐬  𝐞𝐱𝐭𝐢𝐧𝐜𝐭𝐢𝐨𝐧  𝐜𝐨𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭 = 𝐅𝐥𝐮𝐨𝐫𝐞𝐬𝐜𝐞𝐧𝐜𝐞  𝐨𝐫  𝐀𝐛𝐬𝐨𝐫𝐛𝐚𝐧𝐜𝐞  𝐢𝐧𝐭𝐞𝐧𝐬𝐢𝐭𝐲𝐑𝐍𝐀   (𝐌)∗  𝐩𝐚𝐭𝐡  𝐥𝐞𝐧𝐠𝐭𝐡   𝐜𝐦 ∗  𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫  𝐰𝐞𝐢𝐠𝐡𝐭   𝐠𝐦𝐨𝐥𝐞𝐬                   (1) 
 
2.2. Plasmids and site-directed mutagenesis  
Single amino acid substitutions as well as deletions of human PKR were made using 
the pET-PKR/PPase vector. Hamster PKR was cloned into pET28a upstream of lambda 
phosphatase. Thermocycler from Biorad were used for all PCR reactions.  All primers 
were designed and purchased from Integrated DNA Technologies (IDT).  Phusion High 
Fidelity master mixes from New England Biolabs (NEB) were used for all PCR reaction 
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preparations. The pEVOL-pAzF vector used for the expression of p-azidophenylalanine 
(pAzF) specific amino-acyl tRNA synthetase (aaRS)/ tRNAUAG pairs was purchased 
from Addgene.   
2.3. RNA purification 
The strands were deprotected and purified using polyacrylamide gel electrophoresis. 
The RNA bands from the gels were cut and the RNA was extracted by electrolution 
(Elutrap, G.E. Whatman). The RNA was precipitated using 3.5 M sodium acetate/ 99% 
ethanol and dried using a Speed Vac centrifuge. The complementary strands were 
annealed at 80°C for 5 minutes in either AU200 (20 mM HEPES, 200 mM NaCl, 0.1 mM 
EDTA, pH 7.5) or AU75 (20 mM HEPES, 75 mM NaCl, 0.1 mM EDTA, pH 7.5) and 
slowly cooled to room temperature before use. The extinction coefficient of the duplex 
annealed strands was calculated and was usually ~10-25% lower than the sum of the 
extinction coefficient of the individual strands owing to hypochromism. Sedimentation 
velocity analysis was used to ensure that the dsRNAs were homogeneous. 
2.4. Protein expression and purification 
Human PKR constructs were transformed into Rosetta 2 pLyS cells and expressed as 
described previously31. Hamster PKR was expressed and purified differently due to 
reduced solubility. The pET-HamsterPKR/PPase vector was transformed into 
ArcticExpress RIL (DE3) cells which express cold shock proteins Cpn 60 and Cpn 10. 
Cells were grown at 37oC until OD600 was ~0.8 and hamster PKR was induced at 10oC 
for 16 hours. PKR constructs containing amber stop codon substitutions were co-
transformed with p-EVOL-pAzF in ArcticExpress RIL (DE3) cells.  Cultures were grown 
at 37oC and 250 rpm. The aaRS/ tRNAUAG pair were induced at an OD600 of 0.2-0.3 with 
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0.02% arabinose. 1 mM pAzF (Bachem) was added 30 minutes after arabinose 
addition. All subsequent steps were performed in the dark under non-reducing 
conditions. 1 mM IPTG was added after cultures were cooled to 18oC, and induction 
proceeded for four hours at room temperature. All PKR constructs were purified using a 
two-step purification protocol as described previously. Concentrated PKR fractions were 
separated from higher order aggregates by separation over size exclusion column (S-
200/S-75, G.E. Life Sciences) in AU200 buffer (20 mM HEPES pH 7.5, 200 mM NaCl 
and 0.1 mM EDTA). Purified fractions were analyzed using SDS PAGE and 
concentrated using Amicon Ultracentrifugal filters (EMD Millipore) 
2.5. Fluorescent labeling of pAzF-PKR 
Purified pAzF-PKR was labeled with Alexa fluor 488 DIBO (Molecular Probes) or Cy3 
DBCO (Click Chemistry Tools). 10 mM stocks of the dyes were prepared in 99% DMSO 
and stored at 4oC.  Labeling reactions contained 25 µM PKR and 70 µM dye in AU200 
buffer with a reaction volumes of 500 µL. Reactions were incubated for 1.5 hours at 
room temperature and were quenched by buffer exchanging twice into AU200 
containing 0.1 mM TCEP using spin columns containing P6 biogel beads (Biorad). The 
efficiency of labeling was measured by recording the absorbance at 280 nm and 495 
nm or 553 nm for Alexa 488 or Cy3 respectively. 
[Dye]= !"#$%"&'()  !"  !"#  !"  !!"  !"!"#$%&#$!"  !"#$$%&%#'(  !"  !"#∗!"#$  !"#$%&   (M)                                                              (2) 
[PKR]= !"#$%"&'()  !"  !"#  !"  –   !"#$%"&'()  !"  !"#  !"  !!"  ∗  !.!.!"#$%&#$'%  !"#$$%&%#'(  !"  !"#∗!"#$  !"#$%&  (M)     (3) 
 
Labeling Efficiency =100% X [Dye]/[PKR]       (4) 
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Where C.F. is the correction factor used to account for the contribution of the dye 
absorbance at 280 nm. The C.F. for Alexa 488 is 0.11 and is 0.08 for Cy3. The 
extinction coefficients used for human PKR, Alexa 488 and Cy3 were 43,400 M-1 cm-1, 
71,000 M-1 cm-1 and 151,000 M-1 cm-1 respectively. 
2.6. Sedimentation velocity experiments with PKR and dsRNAs 
Absorbance detected sedimentation velocity analysis of PKR-dsRNA interactions was 
performed in AU200 buffer at 20ºC using absorbance optics at 260 nm as previously 
described36. Fluorescence sedimentation velocity experiments were performed using a 
Beckman-Coulter XL-I analytical ultracentrifuge equipped with an AU-FDS 
Fluorescence detector (AVIV Biomedical, Lakewood, NJ) at 20°C and 40,000 rpm 
unless specified. Samples contained 20-30 nM dsRNA and varying concentrations of 
PKR in either AU200 or AU75 buffer were loaded into double sector cells equipped with 
1.2 cm Spin60 charcoal-epon centerpieces (Spin Analytical, Berwick, ME) and quartz 
windows. During a pre-run at 5,000 RPM the photomultiplier voltage and gain multiplier 
settings were adjusted to give ~ 3000 counts and the focus depth was set to give a 
maximum signal. Absorbance intensity scans were recorded for each channel following 
the sedimentation velocity experiment and the meniscus position was determined from 
a characteristic downward intensity spike.  
The protein partial specific volume and the buffer densities and viscosities were 
calculated using SEDNTERP. The partial specific volumes of the dsRNAs were fixed at 
0.55 ml g-1. The sedimentation velocity data for the dsRNAs were first analyzed using a 
c(s) distribution model with Sedfit to ensure that the preparations were homogenous 
and free of contaminants. The data were then fit to a single species model to obtain the 
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sedimentation coefficients and the buoyant molar masses that were then fixed in 
subsequent global analyses of PKR binding. Sedimentation velocity analyses of PKR-
dsRNA interactions were performed as previously described with some modifications to 
accommodate fluorescence data as described below. Initially, the data were analyzed 
using the time derivative method with DCDT+ to obtain g(s*) distributions to define the 
interaction model. Model-dependence global analysis was performed using SEDANAL 
to define the association constants and sedimentation coefficients of the protein-RNA 
complexes. For data acquired with the fluorescence detector, the amplitude of the 
stochastic noise depends strongly on the signal intensity. Therefore, the curve fits were 
weighted by the standard deviation at each point. This also served to convert the RMSD 
reported by SEDANAL from arbitrary fluorescence intensity units to χ, where a value of 
1.0 corresponds to a perfect fit. Joint confidence intervals were obtained using the F-
statistic to define a statistically significant increase in the variance. 
 
2.6. Sedimentation equilibrium analysis of PKR 
Sedimentation equilibrium analysis of PKR self-association was performed in AU200 at 
20ºC or 4ºC as indicated using Rayleigh interference optics.  Six-channel external 
loading cells were used at rotor speeds of 18,000, 22,000, 28,000 rpm. Scans of water 
blanks were collected at each speed prior to running PKR samples. The blank scans 
were subtracted from the samples and data were analyzed using HETEROANALYSIS37. 
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2.7. PKR activation 
Quantitative phosphorylation assays were carried out as previously described by 
incubating 200 nM PKR with varying concentrations of dsRNA in AU75 buffer containing 
5 mM MgCl2 and 0.1mM TCEP at 32 °C for 20 minutes. The phosphorylation reactions 
were initiated with 0.4 mM ATP containing 4 µCi [γ-32P] ATP in each reaction mixture 
and were quenched after 20 minutes by adding SDS sample loading buffer unless 
indicated otherwise. The reaction mixtures were then heated to 90 °C for 3 minutes and 
were analyzed using SDS PAGE electrophoresis and phosphor imaging (Typhoon, GE 
Healthcare). 
2.8.  Steady state fluorescence anisotropy measurements 
Steady state fluorescence anisotropy and emission measurements were recorded with 
a FluoroMax-3 fluorimeter equipped with Glan-Thompson polarizers (Jobin Yvon Inc., 
New Jersey). All measurements were performed at 20ºC with samples in either AU200 
or AU75 buffer using a 10 mm path length quartz cuvette (Precision Cells).  
Fluorescence anisotropy measurements were performed with Alexa 488-labeled 
PKR at excitation and emission wavelengths of 495 nm and 518 nm and bandwidths of 
2 and 3 nm, respectively. Intensities were integrated at each polarization for 5 s with 
three repetitions. The data were corrected for buffer background and the anisotropy (r) 
was calculated as  
   (4) 
where Iǁ‖ and I⊥ correspond to the fluorescence intensity with the excitation polarizer 
oriented in the vertical position and the emission polarizer in the vertical and horizontal 
 
r =
I! −GI⊥
I! + 2GI⊥
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positions, respectively. The G factor corrects for instrument polarization bias and was 
measured to be ~0.64.  
In a cluster of identical molecules undergoing Homo-FRET, the emission is the sum 
of the contribution of the initially excited chromophore and the other chromophores. 
Energy transfer-induced depolarization of the emission and several expressions have 
been derived for the steady state anisotropy expected for a dimeric cluster. The results 
are very similar; here, we use the formalism of Runnels and Scarlatta. 
The total anisotropy of the dimeric cluster (rtot) is the sum of the anisotropy of the 
initially excited chromophore (r1) and the anisotropy of the molecule excited by energy 
transfer (ret)38 
   (5) 
where R0 is the Förster distance and R is the distance between the chromophores.  
In the case of a dimeric cluster with random relative orientation of the chromophores, 
energy transfer results in complete depolarization such that ret = 0.  Even in the case of 
rigid, parallel emission and excitation dipoles, ret is only 0.016. For pAzF261-A488 r1 = 
0.2869, and for the PKR dimer in the back-to-back, antiparallel orientation, R = 25 Å 
(Figure 1B). R0 for Alexa Fluor 488 self-transfer is 48 Å39 and equation S1 (assuming 
ret=0) predicts rtot = 0.145, or about half the monomer value.  An antiparallel PKR dimer 
model was constructed by aligning the PKR kinase (PDB accession 2A1A) onto the 
GNC2 dimer structure (PDB accession 1ZYC) using interface residues conserved 
 
rtot = r1
1+ R0 R
⎛
⎝⎜
⎞
⎠⎟
6
1+ 2 R0 R
⎛
⎝⎜
⎞
⎠⎟
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between PKR and GCN2. In this case, the inter-chromophore distance increases to R = 
49 Å and rtot = 0.195, or about 2/3 of the monomer. 
 
2.9. Small angle X-Ray scattering (SAXS) of ΔV PKR 
SAXS measurements were performed in AU200 buffer at 4oC using a Nanostar 
instrument (Bruker, Madison, WI) equipped with a rotatating anode source and 550 µm 
scatterless pinholes. Proteins were centrifuged at 14,000 rpm for 10 minutes prior to 
measurements. Data were collected in four 1 h frames at a sample-detector distance of 
67.2 cm proving a range of q = 0.007- 0.37 Å-1. Data were reduced using Bruker SAXS 
software. The four scans overlayed, indicating the absence of radiation damage. Buffer 
background scattering (15 1 hour frames) was subtracted from the data prior to 
analysis. Guinier analysis was performed using the low-q portion of the data where 
Rg•q<1.3. The p(r) distributions were produced using GNOM and the maximum 
dimension (Dmax) was manually adjusted to the distance where the p(r) distribution 
approaches zero.  Structural modeling was performing using EOM 2.0. The program 
generated a pool of 10,000 possible scattering intensities using the Ranch software. 
Then a genetic algorithm was applied to obtain a distribution which represents the 
ensemble that fit best to the experimentally obtained scattering curve for the protein. 
The ensemble distribution was for a default set of curves as decided by the algorithm.  
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Chapter 3: Effect of salt concentration on PKR-dsRNAs binding 
 
3.1. Introduction 
Protein kinase R (PKR) is an important component of the interferon-induced innate 
immune pathway3. PKR is synthesized in the cell in a latent, unphosphorylated form and 
becomes activated and undergoes autophosphorylation upon binding to certain host or 
pathogen associated RNAs or upon interacting with the protein PACT.  Activated PKR 
phosphorylates eukaryotic Initiation Factor 2α (eIF2α), causing an inhibition of protein 
synthesis. Many viruses have developed mechanisms to inhibit PKR40. 
PKR contains an N-terminal dsRNA binding domain and a C-terminal kinase 
domain, separated by a flexible linker region. The N-terminal dsRNA binding domain 
(dsRBD) corresponds to the regulatory domain which consists of two tandem copies of 
the dsRNA binding motif, dsRBM1 and dsRBM2. This motif binds duplex RNA in a non-
sequence specific manner but discriminates against ssRNA and dsDNA41.  Each motif 
adopts the conserved αβββα18 fold and they are separated by an unstructured linker of 
~20 amino acids. The crystal structure of a dsRNA-binding domain complexed with 
dsRNA reveals a3 site size of 16 bp11.  The C-terminal kinase domain is the catalytic 
center. The crystal structure of the PKR kinase domain in complex with eIF2α reveals 
that the catalytic center has the canonical protein kinase fold. The complex forms a 
dimer where the interface is in the N-terminal lobe of the kinase domain17.  
PKR is regulated by a variety of cellular and viral RNAs that contain duplex 
regions42.  The most well characterized activators of PKR are simple dsRNAs. There is 
strong evidence that dimerization plays a crucial role in the mechanism of PKR 
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activation by dsRNA5,43. Latent PKR dimerizes weakly in solution but this reaction is 
sufficient to activate PKR in the absence of RNA31. An allosteric pathway has been 
identified that couples the dimer interface with the kinase active site and dimer interface 
mutations can modulate PKR activation17,44.  A hallmark of PKR activation by dsRNA is 
the  “bell-shaped” curve where low RNA concentrations activate but higher 
concentrations are inhibitory12,15. These observations support a model in which multiple 
PKRs assemble on a single dsRNA and high dsRNA concentrations dilute PKR 
monomers onto separate molecules of dsRNA45.   In the context of regular duplex RNA, 
a minimum of 30-33 bp of dsRNA are required to activate PKR autophosphorylation and 
the maximal level of activation increases with duplex length12,13.   .  
The mechanism of assembly of PKR on duplex RNAs has been extensively 
investigated. PKR can bind to duplexes as short as 16-18 bp19,20.  As expected for a 
non-sequence specific interaction, the binding stoichiometry increases with dsRNA 
length12,13,19,20.  The binding stoichiometries for the dsRBM1 and for a construct 
containing dsRBM1 and dsRBM2 are greater than predicted from the site size20,46.  
Based on these results, we proposed an overlapping ligand binding model where the 
motif binds to multiple faces of the dsRNA duplex and overlaps along the helical axis. 
The increase in binding affinity with increasing dsRNA length can be understood as a 
statistical consequence of the greater number of configurations available on the longer 
lattice. The intrinsic binding affinities of a dsRBM1-dsRBM2 construct and full length 
PKR for a 20 bp RNA are similar13,20 but the stoichiometries are lower for the latter.  A 
minimum of 30 bp of dsRNA are required to bind two full length PKR monomers with 
high affinity, which correlates with the minimal dsRNA capable of activating through 
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autophosphorylation.  Binding affinities increase dramatically upon reducing the salt 
concentration from 200 to 75 mM NaCl and a second PKR can bind to 20 bp duplex at 
lower salt13.  
The non-sequence specific interactions of PKR with RNAs are labile and it is 
important to use solution biophysical methods to accurately measure the binding 
parameters at thermodynamic equilibrium. Our previous analyses of PKR binding to 
dsRNA by sedimentation velocity analytical ultracentrifugation13,31 were limited by 
formation of nonspecific aggregates, even at the minimal RNA concentrations required 
for detection using absorption optics. Aggregation is enhanced for longer RNAs and at 
lower salt concentrations. In addition, it is difficult to quantify high affinity binding 
constants due to the limited sensitivity of the absorbance optics.  Here, we have used 
fluorescence detection of labeled dsRNAs to enhance the sensitivity of sedimentation 
velocity measurements and directly characterize the interaction of PKR with duplex 
RNAs ranging from 20-40 bp and at multiple salt concentrations.  The binding affinities 
increase at lower salt concentration and with longer dsRNA length, and in some cases 
the stoichiometries of binding of PKR to dsRNA increase at 75 mM NaCl. The 
dependence of the binding stoichiometries on dsRNA length does not conform to 
standard statistical models for nonspecific binding. We propose a model where the 
activation of PKR by longer RNAs is correlated with an alternative binding mode that 
allows for direct interaction of the kinase domains. 
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3.2. Results 
3.2.1. Sedimentation velocity of PKR and various length duplexes 
The enhanced sensitivity of fluorescence detection in sedimentation velocity 
measurements allows the dsRNA concentrations to be greatly reduced, from ~1 µM 
using absorbance detection at 260 nm to 20-30 nM for fluorescence analysis of 5'-
fluorescein labeled RNAs.  Figure 3.1. shows an analysis of PKR binding to dsRNA 
using a long sequence (40 bp) at low salt (75 mM NaCl), conditions that previously were 
found to promote aggregation. The signal/noise of the raw sedimentation velocity traces 
for the RNA alone is excellent (Figure 3.1.A). The data fit well to a model of a single 
species with a corrected sedimentation coefficient of s20,w = 3.69 S and a molecular 
weight of 30,979 g/mol consistent with a predicted mass of 26,128 g/mol based on the 
RNA sequence. Thus, this dsRNA preparation is homogenous and suitable for analysis 
of PKR binding.  
The binding of PKR to the 40 bp dsRNA was characterized by a sedimentation 
velocity titration using fluorescence detection. Although the general approach is similar 
to the method we have previously described by analysis of PKR-RNA interactions using 
absorbance detection36, the RNA concentration here is much lower and we are able to 
access a much broader range of PKR concentrations, ranging from nM to µM. Another 
difference is that the PKR contributes, albeit weakly, to the absorbance signal measured 
at 260 nm whereas only the fluorescein-labeled RNA contributes to the fluorescence 
signal.  
Initially, the velocity data are analyzed using a model-independent approach to help 
define the correct binding mode. Figure 3.1.B shows a titration of the 40 bp dsRNA over 
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a broad range of PKR concentration from 50 nM to 7 µM, represented as an overlay of 
normalized g(s*) sedimentation coefficient distributions. The formation of PKR-dsRNA 
complexes causes the distributions to shift far to the right, to a saturating value of ~ 9.46 
S at 2 µM PKR.  Hydrodynamic calculations indicate that the magnitude of this shift is 
greater than expected for binding of a single PKR but is consistent with binding of three 
PKR monomers (Table 3.2.).  The g(s*) distribution at 7 µM exhibits a shoulder at higher 
S, indicating formation of higher aggregates. However, the data obtained over the range 
50 nM - 2 µM can be globally fit to a sequential binding model to resolve the three 
equilibrium constants (Figure 3.1.C). The fit is of good quality, with small systematic 
deviations in the residuals and RMSD = 1.70. As we have previously observed for PKR 
binding to dsRNA lattices13,20,46, the first PKR binds most strongly, with Kd1 ~30 nM and 
the second and third ligand bind progressively more weakly, with Kd2 ~ 50 nM and Kd3 ~ 
250 nM Table 3.1.). Note that these are stepwise, macroscopic dissociation constants 
and are not corrected for statistical effects. Fitted values for the sedimentation 
coefficients of the three complexes RNA-PKR, RNA-PKR2 and RNA-PKR3  (Table 3.2.) 
correspond to frictional ratios of 1.42, 1.46, and 1.40, respectively, which lie in the range 
typically observed for RNA-PKR complexes36.  
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Figure 3.1. Sedimentation velocity analysis of PKR binding to a 40 bp dsRNA in AU75.  
(A) Raw sedimentation velocity profiles for 40 bp dsRNA. For clarity, only every 13th 
scan is shown. (B) Normalized g(s*) distributions of 0.03 µM 40 bp dsRNA (black), 
dsRNA + 0.05 µM PKR (blue), dsRNA + 0.3 µM PKR (red), dsRNA + 0.8 µM PKR 
(cyan), dsRNA + 2 µM PKR (green), dsRNA + 7 µM PKR (brown). (C) Global analysis of 
difference curves. The data were subtracted in pairs to remove systematic noise and 
the four data sets at the PKR concentrations were fit to a 2:1 binding model using 
SEDANAL.  The top panels show the data (points) and fit (solid lines) and the bottom 
panels show the residuals (points). The best-fit parameters are shown in Table 3.1.  For 
clarity, only every 7th difference curve of the 165 scans that were fit is shown. 
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Table 3.1. PKR-dsRNA dissociation constants measured in AU75 and AU200 
buffers at 20°C. 
dsRNA 
(bp) 
[NaCl] 
mM 
Model
a 
Kd1 (nM) Kd2 (nM) Kd3 (nM) 
RMSD
b 
20 75 2 
45.2 
(35.2, 59.5) 
54.1 
(40.9, 69.9) 
- 1.54 
20 200 1 
303 
(263, 349) 
- - 1.50 
25 75 2 
7.8 
(6.8, 9.0) 
473 
(391, 572) 
- 1.83 
25 200 1 
438 
(380, 497) 
- - 1.27 
30 75 2 
100.1 
(83.1, 122.5) 
22.6 
(18.6, 26.8) 
- 1.54 
30 200 2 
52.0 
(46.0, 58.3) 
6270 
(3920, 11800) 
- 1.31 
35 75 2 
7.6 
(6.7, 8.6) 
69.1 
(50.8, 95.2) 
- 1.67 
35 200 2 
61.1 
(47.9, 72.8) 
4910 
(2950, 8260) 
 1.38 
40 75 3 
32.1 
(27.3, 38.0) 
52.4 
(40.6, 67.8) 
245 
(212,  280) 
1.70 
40 200 2 
38.1 
(29.5, 47.3) 
813 
(645, 1070) 
- 1.52 
Parameters were obtained by global nonlinear least square analysis of sedimentation velocity 
experiments. The values in parentheses represent the 95% joint confidence intervals obtained 
using the F-statistic. 
aThe model is specified by the stoichiometry of PKR binding. 
b The root mean square deviation of the fit. Because the fits were weighted by the standard 
deviation of the data at each point, a perfect fit corresponds to an RMSD of unity. 
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Table 3.2: Hydrodynamic parameters for dsRNAs and dsRNA-PKR complexes. 
dsRNA 
(bp) PKR:dsRNA
a [NaCl] mM 
Molecular Mass 
(g/mol) s (S) 
s20,w 
(S) f/fo 
       20 0:1 75 13285.2 2.42 2.48 1.58 
       20 1:1 200 75380.2 4.73 5.00 1.39 
20 1:1 75 75380.2 4.83b 5.00 1.39 
20 2:1 75 137475.2 6.26 6.47 1.61 
25 0:1 75 16474.1 2.79 2.86 1.67 
25 1:1 200 78569.1 4.80 5.07 1.53 
25 1:1 75 78569.1 4.91b 5.07 1.53 
25 2:1 75 140664.1 6.79 7.02 1.53 
30 0:1 75 19699 3.05 3.12 1.72 
30 1:1 200 81794.0 5.22 5.51 1.47 
30 1:1 75 81794.0 5.33b 5.51 1.47 
30 2:1 200 143889.0 7.49 7.92 1.39 
30 2:1 75 143889.0 7.68 8.02 1.39 
35 0:1 75 22905.9 3.27 3.36 1.75 
35 1:1 200 85000.9 5.81 6.12 1.38 
35 1:1 75 85000.9 5.93b 6.12 1.38 
35 2:1 200 147095.9 7.32 7.73 1.47 
35 2:1 75 147095.9 8.22 8.49 1.33 
40 0:1 75 26127.9 3.59 3.69 1.76 
40 1:1 200 88222.9 5.97 6.29 1.42 
40 1:1 75 88222.9 6.03b 6.29 1.42 
40 2:1 200 150317.9 7.65 8.08 1.46 
40 2:1 75 150317.9 7.73b 8.08 1.46 
40 3:1 75 212412.9 9.77 10.10 1.40 
a The ratio of PKR to dsRNA in each complex. 
b The sedimentation coefficient in AU75 could not be obtained from global analysis in SEDANAL 
and  was fixed based on the corresponding value obtained in AU200. 
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These results obtained with the 40 bp dsRNA in AU75 demonstrate that it is feasible 
to analyze PKR binding to relatively long dsRNAs, even at low ionic strength, by 
reducing the dsRNA concentration into the nM range using the high sensitivity afforded 
by fluorescence detected analytical ultracentrifugation. We have employed this 
approach to rigorously define the PKR binding stoichiometries and affinities for a 
truncation series of dsRNAs ranging from 20 to 40 bp in 5 bp increments. Binding 
parameters were obtained at both high (200 mM) and low (75 mM) concentrations of 
NaCl.  As described above for the 40 bp duplex, the binding stoichiometries were based 
on the limiting sedimentation coefficients estimated from the shift in g(s*) distributions 
with increasing PKR concentration.  The models were verified and binding constants 
were resolved by global analysis of the data using SEDANAL.  For the measurements 
performed in 75 mM NaCl, where the binding affinity is high, it was not possible to 
reliably fit for the sedimentation coefficients of the intermediate dsRNA-PKR complexes 
due to low population of these species.  The sedimentation coefficients for these 
species were fixed at the values obtained in 200 mM NaCl (corrected for buffer density 
and viscosity). The results of the fits are summarized in Table 3.1. and the 
corresponding hydrodynamic parameters are presented in Table 3.2. 
There are several trends that emerge from the analysis of PKR binding to the RNA 
truncation series at high- and low-salt conditions. For several of the dsRNAs (20, 25 and 
40bp) the apparent binding stoichiometries increase at lower salt. This effect is likely 
associated with the enhancement in binding affinity that occurs at lower salt19. The Kds 
decrease by as much as 10-fold upon reducing [NaCl] from 200 to 75 mM. Thus, the 
second (20 and 25 bp) or third (40 bp) PKR is not detectable at high salt because Kd 
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becomes too high. In most cases, the dissociation constants sequentially increase such 
that Kd1<Kd2<Kd3.  This successive decrease in binding affinities is not due to a 
negative cooperativity but represents a statistical effect. The macroscopic, stepwise 
binding constants measured in sedimentation velocity experiments correspond to the 
product of an intrinsic binding constant k and a statistical factor corresponding to the 
number of microscopic configurations of the ligand on the dsRNA46,47. As the RNA is 
sequentially saturated with ligand the statistical factors decrease, resulting in 
successively weaker binding. As expected for a nonspecific protein-nucleic acid 
interaction, the limiting binding stoichiometries measured in AU75 increase with the 
length of the dsRNA.  However, this trend is surprisingly weak: upon doubling the lattice 
length from 20 to 40 bp the number of PKRs that bind does not double and only 
increases from 2 to 3. 
3.2.2. Activation of PKR by duplexes in low salt 
 It has previously been reported that activation of PKR requires a minimum of 30 bp 
of dsRNA12 and we have correlated PKR activation with the stoichiometry of binding 
measured in AU200 buffer for the dsRNA truncation series13. Our PKR binding data 
indicate a strong dependence of binding stoichiometry on salt concentration. Thus, we 
have re-examined the dependence of PKR activation of dsRNA length in a lower salt, 
AU75 buffer (Figure 3.2.). The activation profiles are very similar to those we previously 
observed at higher salt. A minimum of 30 bp are required to detect activation with a 
maximum near 30 nM and the maximal extent of activation increases with the length of 
the dsRNA.  Thus, although the 20 and 25 bp dsRNAs can each bind two PKRs in 
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AU75 buffer, they are incapable of stimulating autophosphorylation under the same 
conditions. 
 
Figure 3.2.  Activation of PKR by varying length duplex RNAs in 75 mM NaCl. 
Experiments were performed as previously described (10) in AU75 buffer at 32°C. Each 
reaction contains 200 nM PKR, 0.4 mM ATP, 4 µCi [γ-32P]-ATP and the indicated 
amount of RNA. The reaction was allowed to proceed for 20 min at 32°C before 
quenching with SDS loading buffer and resolved on SDS-PAGE.  20bp dsRNA (black), 
25bp dsRNA (blue), 30bp dsRNA (red), 35bp dsRNA (green), 40bp dsRNA (brown) 
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Figure 3.3.  Model for PKR binding to short and long dsRNAs. (A) Domain organization 
of PKR. (B) Two PKRs are able to bind to the 20 bp dsRNA at low salt via dsRBM1.  
PKR binds to dsRNAs of ≥ 30 bp with a larger site size via interaction of both dsRBM1 
and dsRBM2. This binding model facilitates dimerization of the kinase domains, 
resulting in PKR activation. 
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Discussion 
The enhanced sensitivity afforded using fluorescein-tagged dsRNAs with 
fluorescence-detected analytical ultracentrifugation has allowed to us greatly reduce 
RNA concentrations from micromolar to nanomolar.  In contrast to previous studies of 
PKR-dsRNA interactions by analytical ultracentrifugation13, at lower RNA concentrations 
the analysis of binding stoichiometries and affinities is not complicated by aggregation 
formation and we were able to directly characterize the interaction of PKR with duplex 
RNAs ranging from 20-40 bp at multiple salt concentrations. The binding stoichiometries 
obtained here at 200 mM NaCl agree with those obtained earlier except for the 40 bp 
dsRNA, where we previously detected three PKR ligands by fluorescence anisotropy 
and sedimentation equilibrium13 but only two in the present sedimentation velocity 
measurements.  Note that sedimentation velocity has greater resolving power than the 
earlier techniques and small amounts of aggregate may have contributed to a higher 
apparent stoichiometry. The dissociation constants for the 20 and 30 bp dsRNAs in 200 
mM NaCl differ slightly from those previously obtained using absorbance detection. The 
origin of the discrepancies is not clear but the broader PKR concentration range used 
for the present experiments make them more reliable. 
The dependence of the PKR binding stoichiometries and affinities on salt 
concentration and RNA length provides insight into the mechanism of assembly of PKR 
on duplex RNAs and formation of active complexes.  There is a large electrostatic 
component to the PKR-dsRNA interaction19 that results in increased binding affinity as 
the NaCl concentration is decreased from 200 to 75 mM.  The concomitant increase in 
binding stoichiometries for several of the RNAs is likely associated with the 
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enhancement in binding affinity.  Limited solubility of PKR-RNA complexes precludes 
measurements at NaCl concentrations below 75 mM and we make the assumption that 
the stoichiometries measured under these conditions correspond to the maximum. We 
have previously characterized the binding of the PKR dsRBD, containing both dsRBM1 
and dsRBM2, and dsRBM1 alone to the same dsRNA truncation series in AU75 
buffer20,46. The stoichiometries for the full-length enzyme are consistently lower for 
either domain construct across the range of RNA lengths. Presumably, the presence of 
the kinase domain and linker in PKR result in steric hindrance, which increases the 
effective binding site size relative to the domain constructs. 
The dependence of the limiting PKR binding stoichiometries on dsRNA length does 
not conform to standard models for nonspecific binding of proteins to finite nucleic acid 
lattices48-50.  The stoichiometries are expected to regularly increase with RNA length, 
but for PKR they remain fixed at 2 PKR/RNA from 20-35 bp and only increase to 3 for 
the 40 bp sequence. In contrast, the stoichiometries for dsRBM1 binding to RNA 
increase strongly with length and conforms to a modified overlapping ligand binding 
model46 where the motif binds to multiple faces of the dsRNA duplex and overlaps along 
the helical axis with a site size of 12 bp and a minimum overlap of 4 bp20. The dsRBD 
also follows this model for RNAs up to a length of 30 bp but deviates strongly for longer 
RNAs, and the stoichiometries actually decrease between 35 and 40 bp. These data 
indicate a change in binding mode to a larger size with increasing RNA length. This 
model is supported by NMR mapping experiments showing that only the N-terminus of 
dsRBM2 interacts with a 20 bp dsRNA but extensive interactions are observed upon 
binding to the 40 bp sequence20. In addition, affinity cleavage experiments demonstrate 
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that simultaneous binding of both dsRBMs of PKR is correlated with PKR activation51. 
We suggest that an analogous change of binding mode occurs as a function of RNA 
length for the full-length enzyme, resulting in an increase in the site size and a constant 
binding stoichiometry from 20-35 bp. 
Although dimerization clearly plays a critical role in the PKR mechanism43, the 
ability of a single dsRNA to bind 2 PKR monomers is not sufficient to induce 
autophosphorylation.  In AU75 buffer the 20 and 25 bp RNAs each bind 2 PKRs yet are 
incapable of inducing measurable autophosphorylation (Figure 3.2.).  Previously, we 
suggested that the inability of these shorter RNAs to activate in AU200 is associated 
with low binding affinities, resulting in low population of the active (PKR)2:RNA 
species13.  However, the 20 and 25 bp RNAs also do not activate in AU75, yet the 
binding affinities measured in this buffer are as strong as those measured for a 30 bp 
RNA in AU200 where this RNA is capable of activating PKR autophosphorylation. Thus, 
additional factors must be limiting the ability of short RNAs to induce the functional, 
active dimeric form of PKR. We propose that activation of PKR by longer RNAs requires 
a binding mode that inaccessible upon binding to shorter RNAs (Figure 3.3.). Our RNA 
binding data indicate that this active binding state is characterized by a larger size. 
Possibly, this mode is required to allow for direct interaction of the kinase domains to 
mediate functional dimerization.  
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Chapter 4: Assaying PKR dimerization 
 
4.1. Introduction 
The N-terminal regulatory module of PKR consists of two dsRNA binding domains 
(dsRBDs)18. Although the PKR dsRBDs bind dsRNA without sequence specificity19, 
there is evidence for shape recognition and sequence readout in the minor groove in 
some other dsRBDs52. The catalytic domain has the typical bilobal architecture found in 
protein kinases, consisting of a smaller N terminal (N-) lobe and a larger C terminal (C-) 
lobe17. 
A key mechanistic issue is how interaction of the PKR dsRBDs with dsRNA leads to 
activation of the kinase.  Early studies supported an autoinhibition model in which the 
latent form of PKR is locked in a closed conformation where the second dsRBD 
interacts with the kinase and blocks substrate binding43.  In this scenario, RNA binding 
to the dsRBDs leads to an open, active state. This view is supported by NMR chemical 
shift perturbation measurements that reveal interaction between the second dsRBD and 
the kinase53,54. However, this interaction is extremely weak (Kd ~ 250 µM)55.  SAXS34, 
AFM56 and  NMR35 analysis of latent PKR reveal that the long (~90 amino acid) linker 
between the dsRBDs and the kinase domain is flexible and unstructured, giving rise to a 
range of open and closed conformations that is inconsistent with the autoinhibition 
model. 
An emerging mechanism in the regulation of protein kinases is the allosteric linkage 
of dimerization with a conformational transition to an active state57. Structural and 
biophysical analyses support a pivotal role for dimerization in activation43.  The PKR 
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kinase domain forms a dimer in both active, phosphorylated17 and inactive state58.    
PKR dimerizes only weakly (Kd ~ 500 µM); however, this reaction is sufficient to activate 
autophosphorylation in the absence of dsRNA31.  In the context of duplex RNA, the 
minimum length of ~30bp of duplex required to activate PKR 12,13correlates with the 
minimum length capable of binding two PKR monomers with high affinity59. PKR 
activation exhibits a characteristic bell-shaped curve where high dsRNA concentrations 
inhibit12, consistent with a model where PKR dimers are dissociated by dilution onto 
separate dsRNAs45. These results support a PKR activation model where RNA binding 
functions to bring two kinase domains into close proximity and facilitate dimerization.  
Dimerization plays a role in the activation of other eIF2α kinases. PERK 
dimerization is linked to activation60 whereas HRI61 and GCN262 exist as constitutive 
dimers. The structure of a phosphorylated PERK kinase domain reveals a back-to-back 
parallel dimer similar to PKR63. Although a similar N-lobe dimer interface is observed in 
a structure of an unphosphorylated GCN2 kinase domain, it adopts a novel, antiparallel 
orientation where one subunit is rotated approximately 180º64.  Interdimer hydrogen 
bonding (Y323-D289) and salt-bridge  (R262-D266) residues are conserved within the 
family.  Mutations designed to disrupt the salt-bridge in PKR, GCN2 and PERK block 
kinase activity and charge reversal restores biological function44,65,66. This contact is 
formed in the parallel PERK dimer, but the corresponding residues are too far apart in 
the antiparallel GCN2 dimer to form a salt bridge. The antiparallel GCN2 dimer likely 
corresponds to an inactive conformation and activation may be associated with rotation 
to a parallel structure that results in formation of the essential salt-bridge57,64.  
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Interestingly, simultaneous binding of two or more PKRs to an RNA does not 
necessarily activate. For example, at low salt two PKRs can bind RNAs as short as 20 
bp without inducing autophosphorylation59.  Typical protein-RNA interaction 
measurements can count the number of protein monomers bound to an RNA but cannot 
determine whether the proteins directly interact on the RNA to form a dimer. Thus, we 
have developed a sensitive fluorescence assay to direct probe the role of PKR kinase 
domain dimerization in RNA-induced activation. We observe efficient dimerization upon 
binding to activating duplex RNAs. Surprisingly, several non-activating RNAs that bind 
multiple PKRs also induce dimerization. We propose that PKR can adopt an alternative, 
non-activating dimer configuration. 
 
4.2. Results 
4.2.1. Characterization of pAzF-261-A488  
A homo-Förster Resonance Energy Transfer (homo-FRET) fluorescence assay was 
developed to directly monitor dimerization of PKR kinase domains induced by RNA 
binding.   Homo-FRET occurs between fluorophores of the same kind provided the 
Stokes shift is small, and is readily detected by depolarization of the emission using 
steady-state anisotropy measurements. Based on the dsRNA dissociation constants for 
PKR59, the equilibrium populations of PKR dimers are expected to be low and we have 
used homo-FRET to assay PKR kinase domain dimerization due to the high precision of 
the measurement and convenience of labeling.  Because PKR contains 8 cysteines, 7 
of which are highly conserved, unnatural amino acid mutagenesis67 was employed to 
introduce a single p-azido phenylalanine (pAzF) residue into wild-type PKR for labeling 
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with extrinsic fluorophores (Fig. 4.2.A.). Labeling sites were selected based on their 
proximity, solvent accessibility, and lack of interference with the dimer interface. Highly 
conserved residues were excluded.  The K261pAzF mutant was chosen for detailed 
analysis based on high expression, ease of labeling, and efficient homo-FRET.  
K261pAzF PKR reacts readily with Alexa Fluor 488-dibenzocyclooctyne to produce 
a stable conjugate, denoted pAzF-261-A488.  The integrity of the labeled protein was 
monitored by autophosphorylation assays, dsRNA binding, and solution dimerization 
analysis. pAzF-261-A488 is an active kinase and undergoes autophosphorylation upon 
addition of a 40 bp dsRNA at a level about 2.5 -fold higher than unlabeled PKR (Fig. 
4.1.A).  As previously observed for unlabeled PKR13,59, two monomers of pAzF261-
A488 bind to the activating 40 bp dsRNA with comparable dissociation constants (Fig. 
4.1.B).  As assayed by sedimentation equilibrium experiments in the absence of RNA, 
pAzF261-A488 PKR undergoes reversible dimerization with Kd = 94 (85, 103) µM 
(Figure 4.1.C) which is ~5 fold lower than the Kd for dimerization of unlabeled PKR31.  
The enhancement in activation of pAzF-261-A488 relative to unlabeled PKR may be 
due to the tighter dimerization.  This enhancement in dimerization is not observed for 
PKR labeled at position 371, which is more distant from the dimer interface (Kd = 1,260 
µM). However, the energy transfer efficiency is too low for useful analysis. For the pAz-
F261-A488 dimer, the predicted inter-chromophore distance is R = 25 Å (Figure 4.2.B) 
and R0 for Alexa Fluor 488 is 48 Å39, with a corresponding energy transfer efficiency is 
98% and a steady-state anisotropy about half the monomer value.  
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Figure 4.1.: Characterization of pAzF-261-A488. (A) Activation of pAzF-261-A488 by 
40 bp dsRNA. Top:  Phosphorimager analysis of unlabeled PKR (red) and pAzF-261-
A488 (blue) activation. Bottom: quantitation. Data were normalized to unlabeled PKR at 
30 nM 40 bp.  (B) Sedimentation velocity analysis of pAzF-261-A488 binding to 0.75 µM 
40 bp dsRNA. Global analysis of difference curves for at three concentrations of pAzF-
261-A488 fit to a 2:1 binding model provides best-fit dissociation constants of Kd1= 
PKR-p
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0.324 (0.280, 0.376) µM and Kd2 = 0.517 (0.448, 0.579) µM with RMSD = 0.0060 OD. 
The top panels contain the data (points) and fits (lines) and the bottom panels contain 
the residuals. (C) Sedimentation equilibrium analysis of pAzF-261-A488 self-
association. Global analysis of 5 concentrations and two rotor speeds (18000 rpm – 
blue, 28000 rpm – red) to a monomer-dimer model results in Kd = 94  (85, 103) µM with 
RMSD = 0.0327 fringes. (D) Fluorescence anisotropy analysis of pAzF-261-A488 
dimerization in the absence of dsRNA.  Top: raw anisotropy as a function of 
concentration. Bottom: experimental % dimer calculated from the anisotropy data 
compared to the % dimer predicted using the Kd determined by sedimentation 
equilibrium of 94 µM. The slits were adjusted during the titration to maintain the count 
rate in the linear range. 
 
 
 
 
 
 
4.2.2. PKR Dimerization by duplex RNAs 
Significant anisotropy changes are induced by binding of pAz-F261-A488 to duplex 
RNAs (Fig. 4.2.C).  The anisotropy decreases upon addition of dsRNAs ≥ 30 bp capable 
of activating PKR and binding two or more monomers, but non-activating, 20 and 25 bp 
duplexes that bind a single PKR produce negligible anisotropy changes60. Thus, RNA 
binding alone does not significantly affect the steady state anisotropy of pAzF261-A488, 
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and the depolarization induced upon addition of the longer duplexes can be ascribed to 
homo-FRET within kinase domain dimers.  Note that the dsRBD is separated from the 
kinase domain by a long (~ 90 residue) unstructured linker, so that the changes in 
rotational correlation time of the dsRBD due to RNA binding are not expected to affect 
the kinase. 
Quantitative analysis of the anisotropy changes produced by the activating dsRNAs 
provides useful mechanistic insights. The amplitude of the anisotropy change increases 
with the length of the dsRNA, but even for the longest (40 bp) RNA the maximum 
decrease of 12% does not approach the ~50% effect predicted by theory. Also, the 
anisotropy returns to the monomer value at higher RNA concentrations. This behavior is 
consistent with a simulation of the sequential binding equilibria for pAzF261-A488 
interacting with the 40 bp RNA (Fig. 4.2.D). RNA-induced formation of the kinase 
domain dimer requires that two PKR monomers bind to the same RNA. The maximum 
population of the species containing two bound PKRs, denoted RP2, corresponds to 
14% of the total PKR (Table 4.1.) and decreases at higher dsRNA concentration due to 
dilution of PKR monomers onto separate strands.  The amplitude of anisotropy changes 
for the 40 bp dsRNA indicates that a maximum of ~30% of the kinase domains exist as 
dimers (Table 1).  If the kinase domains quantitatively formed dimers upon sequential 
binding of two PKR monomers to an RNA, the ratio of % dimer to % RP2 would equal 
one. For the 40 bp dsRNA this value is about two, implying that the maximum dimer 
population must be overestimated due to additional sources of depolarization, such as a 
small population of RNAs containing three bound PKRs. Regardless of the origin of this 
discrepancy, the shape of the anisotropy titration is consistent with the RNA 
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concentration dependence of the RP2 species and the amplitude implies that RNA-
induced dimerization of the kinase domain occurs efficiently upon sequential binding of 
two PKR to the same RNA. 
 
 
Figure 4.2. Analysis of PKR dimerization induced by activating dsRNAs. (A) 
Conjugation of fluorophores with pAzF-substituted PKR. (B) Structure of the PKR kinase 
domain parallel dimer (PDB accession 2A1A) rendered in PyMol (Schrödinger).  Alexa 
Fluor 488 DIBO conjugated at pAzF-261 was modeling onto the structure, with the 
ligand indicated in stick representation and the chromophore in green.  (C) Anisotropy 
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titrations of pAzF-261-A488 with dsRNAs. Samples contained 200 nM pAzF-261-A488. 
(D) Species distribution for pAz-F261-A488 binding to the 40 bp dsRNA. The fractional 
concencentrations of free protein (P, blue), the the 1:1 complex (RP, red) and the 1:2 
complex (RP2, green) are plotted. The fractional concentrations were determined using 
the experimentally determined dissociation constants Kd1= 0.324 µM and Kd2 = 0.517 
µM (Fig. 4.1).  The width of the distributions correponds to the one standard deviation 
confidence intervals. 
 
 
Control experiments confirm that the dsRNA-induced anisotropy changes are due to 
FRET within kinase domain dimers. The fluorescence anisotropy of pAz-F261-A488 in 
the absence of RNA decreases at high protein concentrations consistent with formation 
of a dimer (Fig. 4.1.D). The extent of dimerization is on the order predicted by the Kd 
measured by sedimentation equilibrium. Addition of unlabeled PKR to pAzF-261-A488 
is expected to reduce the extent of homo-FRET by formation of mixed labeled/unlabeled 
heterodimers. Assuming random formation of heterodimers, the anisotropy change 
should be linearly in the fraction of labeled PKR. For higher oligomers a nonlinear 
dependence is predicted.  Figure 4.3.A demonstrates that mixing increasing amounts of 
unlabeled PKR with pAzF-261-A488 linearly reduces the anisotropy decrease induced 
by binding to a 40 bp dsRNA (R = 0.991 for a linear fit).  Alexa Fluor 488 can serve as 
an efficient FRET donor to Cy3 (R0 ~ 67 Å).  The fluorescence spectrum of a 1:1 mixture 
of PKR labeled at pAzF261 with Alexa Fluor 488 and Cy3 overlays with the sum of the 
spectra of the two components, indicating the absence of FRET (Fig. 4.3.B). Binding of 
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the mixture to the 40 bp dsRNA results in significant donor quenching and enhanced 
Cy3 emission due to hetero-FRET.  These data support the model where binding of two 
PKRs to an activating RNA induces formation of kinase domain dimers.  
 
 
 
Figure 4.3. Depolarization is due to FRET-induced dimerization. (A) Dependence of 
anisotropy on the fraction of labeled PKR. Samples contained 100 nM 40 bp dsRNA 
and 200 nM pAz-F261-A488.  (B) Analysis of PKR dimerization by hetero-FRET. Donor:  
pAz-F261-A488, acceptor: pAz-F261 PKR labeled with DIBO-Cy3. Spectra: 1:1 mixture 
(200 nM total) of donor and acceptor (blue),  1:1 mixture (200 nM total) of donor and 
acceptor with 100 nM 40 bp dsRNA (red), algebraic sum of 100 nM donor and 100 nM 
acceptor spectra (grey). 
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4.2.3. PKR dimerization with catalytically inactive constructs 
In the PKR dimer interface, R262 forms a salt bridge with D266 (Fig. 3A) and 
disruption of this interaction in a R262D PKR mutant blocks kinase activity44.  Similarly, 
disruption of a hydrogen-bonding interaction between Y323 and D289 in PKR Y323A 
reduces activation.  We expected that these mutations block PKR activation by 
preventing kinase dimerization and would serve as negative controls for the homo-
FRET assay. Surprisingly, fluorescence anisotropy titrations indicate that pAzF-261-
A488 containing either interface mutation undergoes dimerization upon binding to the 
40 bp dsRNA (Fig. 4.4.B). The maximal amplitudes of the anisotropy changes are  
somewhat smaller than observed for wild-type PKR with a corresponding Dimer/RP2 ~ 
0.8 (Table 4.1.).  PKR autophosphorylation assays confirm that these constructs are 
inactive (Fig. S2). Consistent with the anisotropy data, sedimentation equilibrium 
analysis of R262D PKR demonstrates reversible dimerization in free solution with Kd of 
923 (714, 1267) µM (Figure 4.4.C), or about 2-fold weaker than WT.  Similarly, Y323A 
PKR also dimerizes with a Kd of 689 (590, 820) µM.  Thus, the disruption of interdimer 
salt-bridge or hydrogen bonding interactions abolishes PKR activation while only slightly 
reducing dimerization affinity. 
 The reduction in the Dimer/RP2 ratio for R262D indicate less efficient dimerization 
or the dimers may have an altered geometry that induces less depolarization. Formation 
of an antiparallel dimer modeled on the GCN2 structure would increase the distance 
between pAzF-261-A488 fluorophores from 25 to 49 Å  resulting in diminished energy 
transfer. To test this model, wild-type and R262D PKR were labeled position 301 where 
the energy transfer efficiency should be enhanced in a GCN2-type antiparallel, inactive 
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dimer relative to the active parallel structure, with interfluorophore distances of 24 and 
60 Å, respectively. Titration of either pAzF-301-A488 or pAzF-301-A488/R262D PKR  
with  40 bp dsRNA results in a similar low amplitude anisotropy change indicating that 
the inactive R262D dimers likely do not adopt a GCN2-type structure.   
The 20 bp dsRNA binds a second PKR upon reducing the concentration of NaCl 
from 200 to 75 mM13,59. Although this short RNA does not activate PKR at either NaCl 
concentration59, it does induce an anisotropy change in 75 mM NaCl (Fig. 4.4.D) 
corresponding to a maximum dimer population of about 9%.  However, PKR binds very 
strongly to the 20 bp RNA at low salt so that the maximum population of RP2 is high 
(49%), resulting in Dimer/RP2 of only 0.19 (Table 4.1.).  Thus, only a small fraction of 
the bound PKRs form dimers upon binding to this short dsRNA. 
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Figure 4.4. Dimerization without activation of PKR. (A) Critical intermolecular salt 
bridge (R262 – D266) and hydrogen bond (Y323-D289) interactions in the PKR kinase 
dimer interface (PDB accession 2A1A) rendered in PyMol (Schrödinger). (B) Anisotropy 
titration of pAzF-261-A488 (red), pAzF-261-A488-R262D (blue) and pAzF-261-A488-
Y323A (green) PKR with 40 bp dsRNA. The anisotropy of the free protein was 
subtracted from each data set. (C) Sedimentation equilibrium analysis of R262D PKR. 
The points are the data and the solid lines are the best fit. For clarity, only every fourth 
point is shown. The inset shows the residuals. Global analysis reveals that R262D 
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dimerizes, with a best-fit Kd = 923 (714, 1267) µM  (the values in parentheses 
correspond to the one standard deviation confidence intervals) and an RMS deviation of 
0.041 fringes. The Kd for WT PKR dimerization under the same conditions is 450 µM. 
(D) Anisotropy titration of pAzF-261-A488 PKR with a 20 bp dsRNA in AU200 and AU75 
buffer. 
 
4.2.4. Dimerization on barrier containing RNAs 
Introducing of helical imperfections into dsRNAs typically reduces PKR binding and 
to activation68,69.  However, PKR is also activated by certain RNAs that contain bulges, 
loops, pseudoknots and single-stranded tails42. PKR can be activated by dimers of 
TAR30 and the HDV ribozyme70 that contain short duplex regions separated by a 
distorted central region that serves as a barrier. To systematically probe the effect of 
structural distortions on PKR dimerization and activation by dsRNA, we introduced 
structurally defined, inert, rigid barriers into a model duplex. The dsRBD interacts with 
the RNA 2'-OH52 and the barriers consist of 2'-O-methyl dsRNA. The RNAs contain two 
15 bp dsRNA regions, the minimal length required to each bind one PKR with high 
affinity, separated by variable length 2'-O-methyl dsRNA barriers and are denoted as X-
Me, where X is the length of 2'-O-methyl dsRNA (Fig. 4.6.A).  PKR is not activated by 
2'-O-methyl dsRNA71 and does not bind to a 15 bp 2'-O-methyl duplex RNA (Fig. 4.5.). 
PKR binding to the barrier-containing RNAs was characterized using sedimentation 
velocity analytical ultracentrifugation.  As expected, each of the RNAs binds two PKR 
monomers (Table 2).  The dissociation constants for 5-Me are similar to a 30 bp dsRNA 
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(zero-length barrier)13.  The dissociation constants for the binding of the first PKR are 
not very sensitive to barrier length but Kd2 increases systematically from 5-Me to 15-Me.  
PKR activation was strongly affected by the introduction of longer barriers (Fig. 4B).  
5-Me activated PKR but 10-Me and 15-Me elicited little to no autophosphorylation. 
These results are supported by previous work where introduction of a 11 bp DNA-RNA 
chimeric duplex between two 20 bp dsRNAs greatly attenuated PKR activation68.  
Binding of pAzF261-A488 to all three barrier-containing dsRNAs results in a significant 
anisotropy decrease due to kinase domain dimerization (Fig. 4C). The maximal 
anisotropy change is slightly attenuated with increasing barrier length, but even for the 
inactive 10-Me and 15-Me constructs it is comparable to that induced by the activating 
30 bp dsRNA. All three RNAs have a high Dimer/RP2, indicating efficient kinase domain 
dimerization. 
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Figure 4.5:  Sedimentation velocity analysis of PKR binding to 2'-OH and 2’-O-Me 
dsRNAs.  Normalized g(s*) distributions of 2.3 µM 15 bp 2'-OH dsRNA (black), 2.3 µM 
15 bp 2'-O-Me dsRNA (blue) 2'-OH dsRNA + 2 eq. PKR (red), 2'-O-Me dsRNA + 2 eq. 
PKR (green). The peak of the distribution for the 2’-OH dsRNA shifts to a higher 
sedimentation coefficient in the presence of PKR due to the formation of a 1:1 complex. 
A similar shift is absent for the 2’-O-Me dsRNA, indicating that PKR does not bind. The 
shoulder present in the 2'-O-Me dsRNA + PKR sample is due to a contribution from free 
PKR (s ~ 3.5 S).  
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Figure 4.6 Interaction of PKR with dsRNAs containing 2’-O-methyl barriers. (A) 
Schematic of 2’-O-methyl (2'-O-Me) barrier-containing dsRNAs. Chimeric dsRNAs were 
designed to contain 5, 10 and 15 bp 2’-O-Me barriers inserted between two 15 bp 
dsRNA regions. (B) Activation of WT PKR by 2’-O-Me barrier-containing dsRNAs.  The 
percent activation is normalized to signal from the 40 bp dsRNA at 100 nM. (C) 
Anisotropy titration of pAzF-261-A488 PKR with 2’-O-Me barrier-containing dsRNAs. 
For reference, the maximal anisotropy changes associated with PKR binding to regular 
30 and 40 bp dsRNAs are indicated by arrows.  (D) Fractional concentrations of the 1:2 
RNA:PKR complex (RP2) for PKR binding to the 2’-O-Me barrier-containing dsRNAs. 
The fractional concentrations were determined using the experimentally determined 
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A B
C
2'-O-Me
15 bp 15 bp
RNA / 2'-O-Me
chimera
D
	   54 
dissociation constants (Table 4.1.). The maximal fraction of RP2 for PKR binding to a 40 
bp dsRNA is indicated with an arrow. 
 
Table 4.1.  Correlation of PKR dimerization and RNA binding. 
Sample Max. % Dimera Max. % RP2b  Dimer / RP2c 
WT + 40 bp 29.5 ± 0.6 14.3 ± 1.4d 2.06 ± 0.21 
R262D + 40 bp 11.4 ± 1.5 14.3 ± 1.4d 0.80 ± 0.13 
Y323A + 40 bp 11.1 ± 2.2 14.3 ± 1.4d 0.77 ± 0.17 
WT + 20 bp 
(75 mM NaCl) 
9.2 ± 0.3 48.8 ± 3.7e 0.19 ± 0.02 
WT + 5-Me 20.9 ± 2.1 18.0 ± 1.6f 1.16 ± 0.16 
WT + 10-Me 11.6 ± 2.3 10.3 ± 1.8f 1.13 ± 0.30 
WT + 15-Me 9.5 ± 1.3 4.7 ± 0.4f 2.02 ± 0.32 
WT + 
HO-ss-dsRNA 
24.2 ± 0.5 15.0 ± 1.2g 1.61 ± 0.13 
WT +  
ppp-ss-dsRNA 
24.6 ± 0.5 21.1 ± 1.8g 1.16 ± 0.10 
aMaximum % dimer calculated from the largest anisotropy change and the anisotropy of the 
dimer  
bMaximum population of RP2 species based on Kd1 and Kd2 for sequential binding of two PKR 
monomers under the conditions indicated. 
cThe ratio of the maximal % dimer to the maximal  % RP2. 
dData from Fig. 1. 
ePreviously reported13 
fData from Table 4.2. 
gMayo C., Wong, C.J. and Cole, J.L. (Submitted). 
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Table 4.2.  Analysis of PKR binding to barrier-containing dsRNAs. 
RNA Kd1 (nM) Kd2 (nM) RMSb 
5-Me 173  
(127, 235) 
375  
(319, 440) 
0.0067 
10-Me 360  
(263, 492) 
784  
(606, 1036) 
0.0082 
15-Me 266  
(231, 306) 
1,930  
(1709, 2194) 
0.0091 
 
Parameters were obtained by global nonlinear least square analysis of sedimentation velocity 
measurements. The values in parentheses represent the 95% joint confidence intervals 
obtained using the F-statistic. 
aUncorrected sedimentation coefficient (Svedbergs). 
bRoot mean square deviation of the fit in absorbance units. 
 
Discussion 
The homo-FRET assay directly probes PKR kinase domain dimerization on RNA 
and provides new insights into the factors that distinguish RNA activators and inhibitors.  
As previously inferred43, dsRNA activators promote kinase domain dimerization and the 
extent of dimerization correlates with activation potency.  These data support a 
dimerization model43,45 where  activating duplex RNAs function to bring PKR monomers 
into close proximity, leading to dimerization of the kinase domains. 
PKR binds to dsRNA nonspecifically in multiple configurations20 so that PKR 
monomers may be quite far apart along the nucleic acid lattice. Thus, it is noteworthy 
that duplex RNA activators ≥30 bp induce efficient dimerization following assembly of 
two PKRs onto a single RNA.  Other proteins harboring dsRBDs can travel along 
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dsRNA by passive diffusion72 and efficient assembly of kinase domain dimers may 
occur via this mechanism. 
In contrast to longer dsRNAs, kinase domain dimerization is inefficient on short, 
nonactivating dsRNA that bind two PKRs in low salt.   The impaired dimerization for 
short duplexes is correlated with a difference in RNA binding mode.  Affinity cleavage51, 
NMR shift perturbation20 and RNA binding analyses20,59  reveal that short dsRNAs that 
fail to activate predominantly interact with dsRBD1 whereas longer activators interact 
extensively with both dsRBDs. Thus, interaction of dsRBD2 with RNA appears to 
regulate kinase domain dimerization despite that fact that these regions are separated 
by a long linker. Although this linker is unstructured in the free enzyme34,35,56, it may 
become at least partially ordered in the presence of RNA and serve to sterically regulate  
kinase domain interactions.  
In contrast to perfect duplexes, the correlation between PKR activation and kinase 
domain dimerization breaks down in the context of more complex RNAs, indicating that 
dimerization is required but not sufficient to activate the kinase.  Abrogation of PKR 
activation by insertion of 2'-O-Me dsRNA barriers ≥ 10 bp does not appreciably affect 
the efficiency of dimerization.  A barrier of 10 bp of A-form RNA duplex corresponds to a 
distance along the helical axis of only ~ 28 Å. It is reasonable that the barrier does not 
disrupt dimerization given that the linker between the dsRBD and the kinase is long and 
would be capable of spanning this short distance.  However, the larger barriers induce a 
change in RNA binding mode that modulates activation, indicating long-range 
communication between the dsRBDs and kinase domain. The structural basis for the 
dramatic dependence of activation on barrier length is not clear.  The effect of barrier 
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length on binding affinity for the second PKR (Table 4.1.) implies that weak cooperative 
interactions that stabilize binding of the second PKR become attenuated as the length 
of the barrier increases. 
The relationship between PKR dimerization and activation can be interpreted within 
the broader context of the other members of the eIF2α family of protein kinases. 
PKR17,73 and PERK63 share a similar back-to-back parallel parallel dimer and 
conservation of interface residues suggests that this structure is a common element 
among the other eIF2α kinases.  We propose that PKR activation requires formation of 
a back-to-back parallel interface. Although R262D and Y323A PKR mutations that 
disrupt interdimer salt bridge and hydrogen-bonding interactions block PKR 
activation44,66 (Fig. 4.4) they do not prevent dimerization at high concentration in the 
absence of RNA or upon binding to an activating dsRNA. Although the energy transfer 
efficiency of pAzF-261-A488 is reduced by these mutations, implying a rearragement in 
the dimer interface, it is not enhanced in pAzF-301-A488/R262D, indicating that the 
inactive dimer does not correspond to the model based on the antiparallel GCN2 
interface.  Some nonactivating RNAs, such as the 20 bp duplex, bind multiple PKRs but 
fail to induce kinase domain dimerization. Other nonactivating RNAs, such as the barrier 
containing molecules, induce formation of an inactive dimer configuration analgous to 
that found in the R262D and Y323A PKR mutants. The allosteric pathway linking the 
PKR dimer interface to the kinase active site is likely disrupted in this configuration17,57.  
The inactive PKR dimer configuration may provide an additional mechanism for 
distinguishing between host and pathogen RNA. High throughput transcriptional 
analysis has revealed the presence of hundreds of dsRNAs in human cells74. PKR must 
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be able to distinguish host RNAs from pathogen-derived molecules to avoid 
inappropriate activation of the innate immunity response. One level of recognition is 
achieved based on dsRNA length, where a minimum of ~30 bp of duplex are required 
for activation12,13,19,59. Here, regulation of PKR is controlled by dimerization; short 
duplexes do not induce dimerization (Fig. 4.4D). In other cases, regulation may be 
controlled by the dimer orientation. Our analysis of 2'-O-methyl barrier-containing 
duplexes suggests that some secondary structure defects may regulate PKR activation 
by induction of inactive dimers and this may serve to prevent aberrant response to host 
transcripts. 
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Chapter 5: Role of the inter-domain linker 
 
5.1. Introduction 
PKR is comprised of two N-terminal dsRNA binding domains (dsRBD) and a C-
terminal kinase domain (Fig. 1a). The dsRBDs are separated by a short (~20 amino 
acid) linker. NMR analysis indicates that this linker is disordered18. In the human 
enzyme, the regulatory and catalytic domains of the protein are separated by a long, 
~90 amino acid linker.  Residues 169-229 at the N-terminal end of the linker have the 
signatures of an intrinsically disordered region (Fig. 1b) with low sequence complexity 
and high content of uncharged polar side chains. The C-terminal portion (229-258) is 
enriched in basic residues. AFM56, NMR35  and SAXS34 indicate that the linker is flexible 
and PKR can adopt a range of closed and open conformations. The PKR kinase domain 
crystalizes as a dimer17,73 and biochemical and biophysical analyses support a pivotal 
role for dimerization in activation43. PKR dimerizes only weakly (Kd ~ 500 µM); however, 
this reaction induces autophosphorylation in the absence of dsRNA31. The isolated 
kinase domain is not autoactivated; however, constructs including the adjoining basic 
region (228-551) or the entire linker (169-551) are activated in the absence of dsRNA, 
implying that the basic domain may contribute to dimerization or regulate activation. 
The role of the long interdomain linker in PKR is not well understood.  There is 
evidence of long-range communication between the dsRBDs and kinase domain. 
Kinase domain dimerization is inefficient on short, nonactivating dsRNA that bind two 
PKRs in low salt (Husain, B., Hesler S. and Cole, J.L., submitted), suggesting that the 
dsRNA binding mode affects kinase dimerization.  Insertion of 2'-O-Me inert dsRNA 
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barriers in the middle of a 30 bp dsRNA blocks PKR activation but does not impede 
dimerization (Husain, B., Hesler S. and Cole, J.L., submitted). Thus, dimerization is 
required but not sufficient to activate the kinase and these barrier-containing RNAs 
induce a nonproductive kinase dimer configuration.  Although the long linker is 
predominantly unstructured in the free enzyme it may become ordered upon binding 
RNA.  Interestingly, the sequence and length of the N-terminal portion of the linker are 
not conserved among mammalian PKR sequences and it is virtually absent in the 
Syrian golden hamster (M. auratus) (Fig. 1b). This natural variability suggests that this 
region does not play a critical role in the activation mechanism. However, the 
contribution of the linker to the structure and function of PKR has not been assessed. 
Here, we characterize the functional properties and conformation of a human PKR 
construct lacking the variable region that is analogous to the M. auratus enzyme. 
Removal of the variable linker results in quantitative but not qualitative changes in 
activation, dsRNA binding and flexibility. 
 
5.2. Results 
5.2.1. Rationale for studying hamster PKR ortholog 
In order to explore the importance of the variable region of the linker, we set out to 
characterize hamster (M. auratus) PKR, a naturally occurring PKR variant in which this 
region is largely absent. Outside of the linker region missing in the hamster enzyme, 
human and hamster PKR are very closely related, with about 60% sequence identity. 
Hamster PKR is does not yield soluble protein when it is expressed in E. coli using 
conditions optimized for the human enzyme31. Expression at lower temperature in Arctic 
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Express RIL DE3 cells that supply cold shock chaperones results in increased solubility. 
However, the Cpn-10 chaperone binds strongly to hamster PKR and it was not feasible 
to produce large amounts of pure enzyme.  Sedimentation velocity measurements 
indicate that hamster PKR binds to a 40 bp dsRNA(Fig. 5.1.A). The g(s*) distributions 
shift to the right with increasing protein concentration. The magnitude of the shift 
indicates that three PKRs bind to the 40 bp RNA. In contrast only two human PKR bind 
to this RNA under identical condition13,59.  Hamster PKR is activated by 40 bp dsRNA in 
a bell-shaped manner analogous to human PKR (Fig 5.1.B). However, the maximum 
extent of phosphorylation is ~8 fold higher for the hamster enzyme. The increased 
activation potency may be associated with the higher binding stoichiometry. 
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Figure 5.1. Functional characterization of Hamster PKR. (a) g(s*) analysis of 40 bp and 
Hamster PKR. 0.75 µM 40 bp dsRNA  was mixed with 1-6 equivalents of Hamster PKR 
and the rate of sedimentation was measured by absorbance AUC.  The shift of the  
peak of the g(s*) distributions to ~ 9S at 6 equivalents corresponds to a 3:1 PKR:dsRNA 
complex. b) Hamster PKR activation by 40 bp dsRNA. Activation was measured with 
various concentrations of dsRNA and 100 nM of hamster (red) and human (blue) PKR 
at 32oC for 15 minutes with 4 µCi of ATP γ-
32
P and 0.4 mM ATP.  The samples were 
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analyzed by SDS PAGE analysis and autoradiography. Hamster PKR is activated ~8 
fold more potently than human PKR. 
 
5.2.2. Functional characterization of PKRΔV 
Due to the practical limitations of obtaining pure hamster PKR we examined an 
analogous construct derived from human PKR in which the variable region (170-228) is 
deleted. This construct, denoted PKRΔV (Fig. 5.2.A), displayed an appreciable 
improvement in solubility and stability relative to hamster PKR.  The activation and RNA 
binding properties of this construct are similar to the hamster enzyme (vide infra). A 
construct lacking the linker sequence, PKRΔVB was also created to probe the 
importance of the more conserved C-terminal basic region of the linker. 
Human PKR is capable of being activated in an RNA-independent fashion at higher 
protein concentrations due to weak dimerization31. Similarly, PKRΔV also undergoes 
RNA-independent autophosphorylation (Fig 5.3.A). The degree of autophosphorylation 
increases with protein concentrations and is significantly enhanced relative to full length 
PKR.  At lower protein concentrations where autoactivation is not present, PKR is 
activated by dsRNAs of 30 bp or longer. Duplex RNAs also induce PKRΔV to undergo 
autophosphorylation with a characteristic bell-shaped activation curve (Fig. 5.3.B).   The 
longest dsRNA examined (40 bp) activates PKRΔV ~2.5 fold more potently than full 
length PKR and the maximum occurs a low dsRNA concentration of 3 nM compared to 
about 30 -100 nM for the full-length enzyme.  The 30 bp dsRNA is a poor activator of 
PKRΔV and no activation is detected for the 20 bp duplex. 
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Figure 5.2.  PKR domains and linker regions. (a) Domains of PKR and linker deleted 
constructs. The interdomain linker contains a variable region (169-229) and a basic 
region (229-258) depicted as blue and red solid lines respectively. The middle and 
bottom panels show the regions of the linker deleted and the corresponding construct 
nomenclature (b) Linker sequence alignment. Sequence alignment of the linker regions 
from various PKR homologs were aligned and illustrated using SeaView75. The residues 
are coloured based on their charge and hydrophobicity. The alignment shows the 
clustering of basic residues in the C terminus of the linker whereas the variable region is 
in fact variable in length across species. 
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Figure 2. Effect of variable linker region on PKR activation. (a) dsRNA-independent 
activation. The extent of PKR (blue) and PKR ΔV (red) autoactivation was measured at 
0.05 – 2 µM at room temperature following 10 minute incubation with 4 µCi of ATP γ-
32
P. 
PKR ΔV auto-activation is ~10 fold greater than for PKR.  (b) dsRNA-induced activation. 
PKR ΔV activation was monitored at 0.1 µM with varying concentrations of 20 bp 
(black), 30 (blue) and 40 bp (red) dsRNA. The percent activation is normalized against 
the percentage of PKR activation by 0.03 uM 40 bp dsRNA.  The activation shows a bell 
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shaped curve and both 20 and 30 bp dsRNAs are poor activators. 40 bp dsRNA 
activated PKR ΔV  ~2.5 times more potently than it does PKR.  
 
5.2.2. Dimerization of PKRΔV 
To test whether the increased activation of PKRΔV is due to enhanced 
dimerization, the dimer dissociation constant of PKRΔV was measured by 
sedimentation equilibrium (Fig. 5.4.). Data were collected over a protein concentration 
range of 0.25 - 2 mg/ml and two rotor speeds and were globally fit to a monomer-dimer 
equilibrium model. The best fit Kd = 1.75 (1.43, 2.21) mM, which is about three-fold 
weaker than for full length PKR31. Thus, deletion of the variable portion of the linker 
actually reduces the dimerization affinity, indicating that the enhanced degree of RNA-
independent autophosphorylation of PKRΔV must be due to other effects. 
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Figure 5.4. Dimerization of PKR ΔV. The Kd for self-association of PKR ΔV was 
measured using sedimentation equilibrium. The data  (empty circles) were collected for 
0.25 mg/mL, 0.5 mg/mL, 1 mg/mL and 2 mg/mL at 28000 rpm (red) and 18000 rpms 
(blue). The data were fit to monomer-dimer equilibrium (solid lines) using 
Heteroanalysis and the K
d
 = 1.75 (1.43, 2.21) mM.  The residuals are presented in the 
inset as solid circles.  
 
	   68 
5.2.2. PKRΔV binding to duplex RNAs 
The stoichiometries and affinities for PKRΔV binding to dsRNA were measured 
for 20- 40 bp sequences using sedimentation velocity and compared with full length 
PKR.  The stoichiometries were determined from the magnitude of the shift in the g(s*) 
sedimentation coefficient distribution function upon titration of the dsRNA with protein36. 
For the 40 bp dsRNA, addition of 6 eq. of PKRΔV induces a large shift from ~ 3.5 S to ~ 
8 S (Fig. 5.5.A), which is higher than the sedimentation coefficient for the 2:1 complex 
formed with full length PKR59. Thus, three PKRΔV bind to the 40 bp dsRNA in AU200 
buffer whereas only two full-length PKR monomers bind under comparable conditions. 
The data obtained at four protein concentrations were globally fit to this model using 
SEDANAL (Fig. 5.5B). A good fit is obtained with a low RMS deviation of 0.0070 OD 
and small residuals. The best-fit Kds for the first and second PKR binding events are 75 
nM and 56 nM respectively with considerably weaker binding of the third monomer 
(Table 1).  The value of Kd1 is similar to that observed for the full length enzyme but Kd2 
is tighter59, suggesting enhanced cooperativity of binding.  
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Table 1. Binding constants for PKRΔV and duplex dsRNAs 
RNA Kd1 (nM) Kd2 (nM) Kd3 (nM) RMSDa 
20 bp 235 (189, 286) - - 0.0079 
30 bp 77 (24, 215) 865 (480, 1700) - 0.0160 
40 bp 75 (43, 121) 56 (27, 99) 2,290 (1,380, 3.870) 0.0070 
Parameters obtained by global nonlinear least square analysis of sedimentation velocity 
experiments. The values in parentheses represent the 95% joint confidence intervals obtained 
using the F-statistic.  
aRoot mean square deviation in absorbance units. 
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Figure 5.5. Effect of variable linker region on RNA binding. (a)  g(s*) analysis. PKR ΔV 
binding to 40 bp dsRNA was measured using absorbance sedimentation velocity 
measurements. 0.75 uM 40 bp concentration was fixed and increasing equivalents of 
PKR ΔV were analyzed. The g(s*) analysis perfomed using DCDT+ shows that the peak 
of the distributions shifts to higher S indicating that protein-RNA complexes are being 
formed.  (b) Global analysis. The data at all PKR ΔV concentrations were fit globally 
(a)
(b)
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using Sedfit to a 3:1 binding model. The dissociation constants and rmsds are 
presented in Table 1. 
  
5.2.2. Conformation analysis of PKRΔV by small angle X ray scattering (SAXS) 
Human PKR contains two flexible linker regions and adopts a range of compact and 
extended conformations34. The contribution of the variable linker region of PKR to 
flexibility was determined by small angle scattering analysis of PKRΔV.  Data were 
collected over a concentration range from 1 - 5 mg/ml. The parameters derived from 
Guinier and GNOM analysis did not vary substantially over this concentration range so 
the data at the highest concentration were used for further analysis.  A linear Guinier 
plot (Fig 5.6.A) indicates the absence of aggregation. The radius of gyration (Rg) of 33.3 
Å is substantially smaller than for full length PKR (~ 40 Å)34, indicating that PKRΔV does 
not adopt as extended a conformation as the wild type protein. Similar to full length 
PKR, the p(r) distribution of interatomic distances peaks at about 30 Å with a tail to 
longer distances, suggesting the presence of flexible regions.  However, the Dmax for 
PKRΔV is smaller (110 Å) relative to full-length PKR (175 Å).   A Kratky plot of the 
scattering data (Fig. 5.7.) exhibits a peak at lower q and rises at higher q, which is 
characteristic of proteins containing both folded and disordered regions. 
 Based on the evidence that PKRΔV retains flexibility we have pursued structural 
models consisting of three folded domains (dsRBD1, dsRBD2 and kinase) connected by 
linkers that can adopt multiple conformations. The EOM76,77 program was used to 
generate a large (10,000) pool of structures and select a minimal ensemble from this 
pool that best fits the SAXS data. Figures 5.6.C and 5.6.D show distribution of Rg and 
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Dmax, respectively, for the initial pool and the ensembles selected by EOM. In both 
cases, the selected structures exhibit broad distributions, indicating the contribution of 
compact and extended conformations to the ensemble. However, the distributions are 
biased towards more compact conformations relative to the random pool, suggesting 
the presence of attractive interactions between domains. We have confirmed that 
PKRΔV is flexible by fitting the SAXS data using EOM using an ensemble size of one or 
alternatively, by rigid body modeling of single structure using BUNCH78. The  Χ2 of the 
fit increases from 0.996 in the default EOM analysis to 1.303 using an ensemble of one 
and 1.56 using BUNCH (data not shown). 
 The Rg distribution and to a lesser extent, the Dmax distribution, appears bimodal. 
This observation implies that PKRΔV may cluster into two families of compact and 
extended conformations.  Consistent with this picture, the Χ2 of the fit increases only 
slightly to 1.056 as the ensemble size is reduced to two.  However, simulations indicate 
that such bimodal distributions may be artifactual.  A continuous distribution of 
structures was simulated by selecting ten conformations from the pool with amplitudes 
derived from the pool distribution. Noise equal to the experimental PKRΔV scattering 
was added and the resulting simulated data set was fit using EOM with the same pool.  
Interestingly, the selected distribution was also bimodal and reducing the ensemble size 
to two results in only a marginal increase in Χ2 from 1.023 to 1.040. Thus, the bimodal 
shape of the PKRΔV distribution does not necessarily imply the presence of two families 
of conformers.   Repeating this process using noise-free data resulting in a selected 
distribution that reproduced the underlying pool more faithfully, indicating that the noise 
level is an important determinant of the quality of the distributions produced by EOM.  
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Figure 5.6. SAXS analysis of  PKRΔV conformation.  Data were collected at 4ºC at a 
protein concentration of 5 mg/ml.  (a) Scattering data (points) and fit to the p(r) 
distribution (solid red line). Inset: Guinier analysis yields Rg = 33.3 ± 0.2 Å. (b) p(r) 
distance distribution produced by transforming the data in part (a) using GNOM. Rg (c) 
and Dmax (d) distributions produced by fitting the the data in part (a) using EOM. The  
distributions of the random pool of 10,000 structures are shown in black dotted lines and 
the distributions selected by the genetic algorithm to fit the experimental data are shown 
in solid blue. The error bars correspond to the standard deviations of the distributions 
produced from three runs of GAJOE. 
   
 
(a)
(b)
(c)
(d)
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5.3. Discussion 
It is noteworthy that the length of the interdomain linker in PKR orthologs is highly 
variable, leading to the question of how this variable region affects the structure and 
function of the enzyme. This region is virtually absent in M. auratus PKR and we initial 
sought to compare this construct to human PKR. However, M. auratus is difficult to 
obtain in purified form.  We created an analogous deletion construct of the human 
enzyme, PKRΔV, which is highly homologous to the M. auratus enzyme and was 
chosen as a suitable alternative to probe the role of the variable linker. Control 
experiments verify that PKRΔV behaves similarly to M. auratus PKR.  
A key observation to emerge from our analyses is that the removal of the variable 
region of the linker results in quantitative but not qualitative changes in the  catalytic 
activity, RNA binding and conformational properties of PKR. The PKRΔV construct 
retains enzymatic activity and undergoes both RNA-independent and RNA induced 
phosphorylation. The enhanced autoactivation of PKRΔV indicates that the linker in 
human PKR negatively regulates the rate of PKR autophosphorylation.  This 
enhancement is not simply due to higher affinity dimerization. PKR autophosphorylates 
at multiple sites lying within the kinase domain, the basic region and the dsRBD58,79-81. 
Potentially the variable length linker separates the domains and limits the rate with 
which the kinase domain catalyzes cis phosphorylation of sites within the dsRBD. 
Deletion of the linker may allow more rapid phosphorylation of serines and threonines in 
the dsRBD due to induced proximity.   Alternatively, the variable region may act as a 
steric barrier that limits access to the sites located in the dsRBD.  
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As previously observed, the PKRΔV construct exhibits a bell-shape curve for 
activation by dsRNA where high concentrations inhibit due to dissociation of PKR 
dimers onto separate RNAs12,45. The length dependence of dsRNA activation can be 
correlated with binding stoichiometry: like full - length enzyme, 30 bp is the minimal 
length capable of binding two PKR and exhibits slight activation. The RNA binding 
affinities are similar to those we previously reported for PKR59 with some enhanced 
affinity for the second PKR binding the 30 and 40 bp dsRNAs and detection of a third 
PKR binding to the 40 bp sequence.  Previously, we only detected a third PKR binding 
to this sequence upon reducing the NaCl concentration from 200 to 75 mM. The 
enhanced affinities for the second and third PKR binding suggests that removal of the 
variable linker region enhances cooperativity of PKR assembly.  The enhanced 
activation of PKRΔV by the 40 bp dsRNA is likely correlated with the increased binding 
affinity for the second and third monomers. 
SAXS analysis reveals that PKRΔV retains significant conformational flexibility 
despite the removal of the bulk of the interdomain linker.  The shapes of the Kratky plot 
and p(r) distribution are characteristic of proteins containing disordered regions.  
Structural modeling treating the regions lying between dsRBD1 and dsRBD2 and basic 
region as flexible linkers reveals that good fits to the scattering data require models that 
incorporate an ensemble of conformations. Although we cannot ascribe significance to 
the bimodal shapes of the Rg and Dmax distributions, they are clearly biased towards 
more compact distributions that than the random pool. Similar bias was observed in our 
previous SAXS studies of full length PKR34. NMR chemical shift perturbation18,53 
measurements indicate interactions between dsRBD2 and the kinase domain that may 
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be responsible for the compaction of the ensemble. This interaction is weak and is 
expected to lead to population of both closed and open states55. The persistence of this 
conformational bias in PKRΔV implies that the basic linker region remains flexible to 
allow the kinase and dsRBD2 to interact; however, further investigation is require to 
parse the contributions of the dsRBD1-dsRBM2 linker and the basic region to the 
overall flexibility of the PKR.   
Our observation that the structural and functional properties of PKR are not strongly 
affected by the presence of the variable linker region leads to the questions: why does 
this region exist and why do different PKR orthologs contain different length linkers?  
PKR is activated by a diverse array of RNAs, some of which contain extensive tertiary 
structure42, and we have previously suggested that flexible tethers would permit 
dimerization of kinase domains and activation in cases where the dsRBDs of two PKR 
monomers are bound at more distal regions of the RNA activators. 34 In this case, the 
effects of linker length would become more pronounced for RNAs that contain duplex 
binding sites that are far apart.  However, PKRΔV is not more susceptible than the full-
length enzyme to the effects of insertion of 2'-O-Me dsRNA barriers in the middle of a 
30 bp dsRNA (data not shown). Further investigation using a more diverse range of 
PKR ligands may reveal substantial linker dependence. Alternatively, unstructured 
regions are often involved in protein-protein interactions82 and PKR is involved in a 
plethora of signaling pathways9,10,83 that may be dependent on interactions with the 
unstructured linker. 
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Chapter 6: The role of the second dsRNA binding domain  
 
6.1. Introduction 
PKR contains two N-terminal dsRNA binding domains (p20) separated by a 20-residue 
unstructured linker.  Both domains bind preferentially to A form dsRNAs19, and the 
interaction is primarily non-sequence specific 18. Although both domains comprise of a 
canonical αβββα motif the dsRBD1 binds dsRNA with a higher affinity than dsRBD2. 
However, both domains are required for the high affinity interaction (~30 fold higher) of 
p20 to dsRNA, thus indicating that binding is cooperative20,84. Most dsRBD-containing 
proteins possess a single copy. It is unclear if dsRBD2 plays a role exclusive of simply 
enhancing the overall dsRNA binding affinity. PKR is able to bind short duplexes 
between 16-18 bps. However, a minimum of 30 bp is required to induce PKR 
autophosphorylation12,13. NMR HSQC analyses of p20 show significant chemical shift 
perturbations of residues spanning both dsRBD1 and 2 upon 40 bp binding20. Yet, 
binding to 20 bp dsRNA produces perturbations within dsRBD1 and in the N terminal 
regions of dsRBD2.  Affinity cleavage experiments performed to map the binding site for 
p20 and various dsRNA ligands show that both dsRBDs interact with activating 
dsRNAs, whereas only a single dsRBD binds to non-activating ones51. These results 
suggest that PKR activation is correlated with the binding of both dsRBDs to the 
dsRNA, whereas non-activating dsRNAs bind dsRBD1 and are unable to bind the entire 
dsRBD2.  In order to elucidate the importance of the dsRBD2 we created mutations 
sequentially in various regions within the domain that are predicted to make dsRNA 
contacts. The objective of this study was to create a construct that was able to bind 
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dsRNA solely via the dsRBD1 regardless of the dsRNA ligand and test the importance 
of dsRBD2 binding on activation. dsRNA binding and activation was measured with the 
dsRBD2 mutants and 1H-15N HSQC measurements were performed to confirm that the 
dsRBD2 interaction was abolished.  
6.2. Results 
6.2.1. Rationale for the selection of dsRBD2 mutants 
There is currently no structure available of the complex of PKR’s dsRBD with dsRNA. A 
structure of a canonical Xlrbpa-2, bound to dsRNA confirmed that binding is non-
sequence specific and that majority of the interactions occur between charged polar 
amino acids and 2’OH and phosphodiester oxygens on the dsRNA11. Xlrbpa-2 footprint 
on the dsRNA spans two minor grooves and the intervening major grove. The binding 
interface comprised of regions 1, 2 and 3 on Xlrbpa-2. The corresponding residues in 
dsRBD1 and dsRBD2 are shown in Fig. 6.1.A. Alanine substitutions in dsRBD2 were 
made sequentially to estimate the relative importance of each region. The locations 
were selected based on sequences conservation with Xlrbpa-2 and their solvent 
accessibility. K150A mutation was previously found to be critical for dsRNA binding51. A 
construct containing substitutions H126A, K150A and Q151A (KQH) was created to 
eliminate contacts predicted to occur within regions 2 and 3. A quad mutant with an 
additional N106A (KQHN) was made to eliminate contacts in all three regions. We 
chose to abolish dsRBD2 binding by making point mutations rather than deletion the 
domain as a whole to more closely match a physiological construct and to avoid any 
perturbation of PKR’s overall structure or dynamics.               
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Figure 6.1. Model for intermolecular interactions between dsRBD2 and dsRNA. A) 
Sequence alignment of PKR dsRBD1, PKR dsRBD2 and Xlrbpa-2. Residues in regions 
1 (red), 2 (blue) and 3 (green) are highlighted in bold. B) The structure of a complex of 
Xlrbpa-2 with dsRNA (PDB accession 1DI2) was used to develop a model for the 
interaction of PKR dsRBD2 with dsRNA (green). PKR dsRBD2 from the NMR structure 
of dsRBD1-dsRBD2 (PDB accession 1QU6) was aligned with Xlrbpa-2 and rendered in 
PyMol (Schrödinger). Xlrbpa-2 (ribbon, cyan), dsRNA (stick, beige), PKR dsRBD2 
(ribbon, green). Key conserved residues that form the dsRNA-binding interface 
spanning regions 1, 2 and 3 are indicated.  
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6.2.2. Characterization of dsRBD2 mutants 
The effects of the dsRBD2 mutations on dsRNA binding were assessed by 
characterizing their interaction with 40 bp dsRNA by sedimentation velocity analytical 
ultracentrifugation. Initally, the PKR mutants were characterized in the absence of RNA 
to determine homogeneity and conformation. The sedimentation coefficients of the PKR 
mutants were determined by fitting the sedimentation velocity data to a single species 
model. The sedimentation coefficients of the mutants are similar to that of WT PKR 
(Table XX: Show s20,w) indicating that the mutations do not perturb the native 
conformation of the free enzyme. All constructs bound 40 bp with a 2:1 stoichiometry, 
similar to WT PKR. RNA binding titrations were performed with increasing 
concentrations of each dsRBD2 mutant and fixed concentration of 40 bp dsRNA (0.5 
µM). The Kd1 for binding increases ~ 4 fold for the K150A mutant compared to WT PKR 
(Table 6.1). Mutagenesis of residues K150, Q151A and H126A, spanning regions 1 and 
2 of the binding interface results in further weakening of binding (~10 fold for Kd1). 
Interestingly, Kd2 remains unaffected. However, addition of the N106A mutation causes 
a ~ 4 fold decrease in Kd2 as well. Activation of the three constructs was measured with 
40 bp dsRNA (Figure 6.2).  The reactions contained fixed amounts of protein (0.2 µM) 
and 0-3 µM of 40 bp dsRNA and they were initiated by the addition of 4 µCi of [γ-32P] 
ATP and 0.4 mM ATP. The autoradiograms show that the KQN mutant does not exhibit 
an appreciable difference in dsRNA-induced autophosphorylation compared with WT 
PKR (Figure 6.2.A). However, the KQHN is virtually incapable of activation above 
background levels (Figure 6.2.B). These results indicate that either the combination of 
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N106A with the other mutations resulted in the complete loss of dsRBD2-dsRNA 
binding or that N106A alone is capable  
Table 6.1. Binding constants for 40 bp and dsRBD2 mutants 
PKR construct Kd1 (nM) Kd2 (nM) RMSDa 
K150A 162 (119, 221) 429 (350, 509) 0.0070 
K150A,Q151A, 
H126A 
484 (292, 818) 323 (241, 425) 0.0122 
K150A,Q151A, 
H126A,N106A 
341 (217, 529) 1694 (1273, 2290) 0.0106 
Parameters obtained by global nonlinear least square analysis of sedimentation velocity 
experiments. The values in parentheses represent the 95% joint confidence intervals obtained 
using the F-statistic.  
aRoot mean square deviation in absorbance units 
                 
Figure 6.2: Simulation of fraction RNA-PKR2 for wild type and KQHN PKR. The 
simulation was performed using IGOR Pro (Wavemetrics Inc) using the dissociation 
constants for WT and KQHN PKR and 40 bp dsRNA.     
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Figure 6.3: Activation of dsRBD2 mutants by 40 bp dsRNA. A) Activation of KQH 
PKR B) Activation of KQHN PKR. Activation assays were performed with 0.2 µM PKR 
and 0 – 3.0 µM 40 bp dsRNA in AU200 buffer. Reactions were initiated by adding 4 µCi 
of [γ-32P] ATP and 0.4 mM ATP for 40 minutes at 32oC. Samples were analyzed using 
SDS PAGE and autoradiography. 
 
 
 
 
 
6.2.3. 1H-15N HSQC analysis of dsRBD 
The KQHN construct was designed to abolish dsRBD2 binding to dsRNA. The decrease 
in binding affinity indicates that the interaction of dsRBD2 with RNA is affected, but does 
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not prove that binding is completely eliminated. NMR chemical shift perturbation 
experiments were used to directly probe PKR-RNA interactions at the single residue 
level. Experiments were conducted with p20 with and without KQHN subtitutions (Figure 
6.4) Spectra were collected with 0.1 mM p20 and p20-KQHN under conditions used 
previously. The spectra were overlaid and several of the crosspeaks, mainly those in the 
dsRBD2 had shifted in the KQHN p20 (Figure 6.5).  
  
 
Figure 6.4: Schematic of dsRBD construct for NMR HSQC analysis. dsRBD2-
dsRNA interaction or lack thereof was determined using 1H-15N HSQC analysis with and 
without 40 bp dsRNA.  
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Figure 6.5: 1H-15N HSQC analysis of p20 and KQHN p20. The spectra were acquired 
on Varian Inova 800 MHz instrument with 0.1 mM p20 or quad mutation (K150A, 
Q151A, H126A, N106A) in 20 mM sodium phosphate, pH 6.6, 100 mM sodium chloride, 
0.1 mM TCEP at 25oC. Existing assignments of p2085 were mapped onto the spectra 
using CcpNMR analysis 86. 
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Figure 6.6: Analysis of normalized peak intensities upon dsRNA titration. Normalized 
intensity for p20 (black) or  KQHN p20 (red) with A) 3.5 µM 40 bp dsRNA and B) 6.95 
µM 40 bp dsRNA.  
 
 
	  
	  
dsRBD1 dsRBD2 
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The spectra for p20-KQHN is well dispersed, indicating that the construct is well folded 
and that although the mutagenesis caused small local changes in the environment of 
dsRBD2 the overall conformation remained similar to WT p20. The existing 1H-15N 
HSQC spectral assignments for p20 were mapped on the spectra 18(Figure 6.5). The 
spectra under our conditions were slightly shifted overall compared to the original 
assignments, likely due to subtle changes in experimental conditions. 0.35 and 0.695 
equivalents of 40 bp dsRNA was titrated into p20 and KQHN-p20 samples and the 
spectra were collected. No clear peak shifts were observed upon dsRNA addition, 
however, the overall peak intensities decreased with increasing dsRNA concentrations. 
The normalized intensities for the assigned residues were plotted and compared 
between WT p20 and KQHN p20 at each dsRNA concentration (Figure 6.6). An overall 
decrease of ~40% was observed with residues in dsRDB1 for WT p20 compared to ~ 
80% in KQHN-p20 (Figure 6.6.A With 0.35 equivalents of 40 bp dsRNA the residues in 
dsRBD2 are less perturbed than dsRBD1 for both p20 and KQHN p20. However, the 
relative differences in perturbation in the two domains are far greater for KQHN-p20. 
These results may suggest that dsRBD2 in KQHN p20 may not interact directly with the 
dsRNA.  At 0.695 equivalents of 40 bp dsRNA the intensities decreased further in 
dsRBD1 and dsRBD2 for both constructs. The overall reduction in the intensities may 
be a consequence of the formation of large heterogeneous RNA-PKR complexes in 
solution due to the complex equilibria for p20-RNA interaction20. Further HSQC 
analyses are required to conclusively ascertain whether dsRBD2 binds dsRNA in the 
KQHN construct. The overall decrease in the intensity of the cross peaks may be 
reduced by mixing 40 bp and p20 in stoichiometric proportions. This should produce a 
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homogeneous mixture of RNA-p201 species over higher order complexes such RNA-
p202, RNA-p203 and RNA-p204, which are likely to contribute to the broadening of the 
cross peaks.  
6.3. Discussion  
PKR contains two tandem dsRBDs which bind variable length dsRNAs. The footprint of 
a single dsRBD on dsRNA is ~16 bps18. Only dsRNA with lengths 30 bp or higher can 
activate PKR.  dsRBD1 binds dsRNA tighter than dsRBD2, but both motifs are required 
for high affinity interaction with dsRNA. NMR20, AUC20, and affinity cleavage51 
experiments provide evidence to suggest that dsRBD2 is required to bind to dsRNA to 
induce activation. To test the model we sequentially mutated key residues predicted to 
participate in the dsRBD2-dsRNA binding interface. Functional characterization of the 
mutants were performed and it was observed that KQHN did not activate with 40 bp 
dsRNA. The KQH mutant, however, is still active and the Kd2 remains unaffected 
compared to WT PKR. The binding affinities of KQHN compared to WT PKR were 
weaker for Kd1 by ~ 10 fold and ~4 fold for Kd2. The weakening of Kd2 with the KQHN 
and not KQH may suggest that the dsRBD2 of the second PKR may bind 40 bp via 
region 1 alone, whereas that of the first PKR binds via all three regions. The abolishing 
of activation with the KQHN mutant may be due to a cumulative effect of mutating all 
three regions of the dsRBD2. Alternately, the effect could be due to N106A alone, 
suggesting that it is a key regulatory residue in the dsRNA binding and activation. 
Further characterization of a single N106A mutant is required to ascertain the role of 
N106 in PKR activation. Viral and cellular RNAs with complex secondary structures are 
able to bind and activate PKR. dsRNAs containing 2’-O-methyl barriers between 15 bp 
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duplex stretches are able to bind two PKRs but do not induce activation(Bushra Husain, 
Stephen Hesler, James Cole; 2015). Notably, differences in the dsRNA structure and 
composition can translate to inability for PKR activation suggesting a mechanism for 
inter-domain communication. This may occur either through the inter-domain linker or 
perhaps through transient interactions between dsRBD2 and the kinase domain. In such 
as scenario, the role of the dsRBD2 may be more significant than to simply serve as a 
redundant domain required for high affinity binding of the dsRBD to dsRNA through 
cooperative assembly. 
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Chapter 6: Conclusions and future direction 
 
  
During viral infection PKR recognizes RNAs that possess an array of complex 
secondary structural elements such as bulges, loops and mismatches68. Despite PKRs 
preference for duplex stretches of dsRNA it is still able to bind and become activated by 
structured RNAs. Viruses synthesize decoy RNAs such as VAI from Adenovirus and 
EBER1 and EBER2 from Epstein Barr virus, which bind and sequester PKRs in solution 
minimizing the PKR-mediated response87,88. An elusive aspect of this inhibition process 
is the ability for PKR to distinguish non-activating and activating RNAs, since many of 
them possess similar structural features.  
The assembly of more than one PKR on a dsRNA is critical since activation is 
linked closely with dimerization. A FRET–based dimerization assay was presented 
(Chapter 4) which allowed us to directly probe PKR dimerization upon dsRNA binding.  
The results showed that dsRNAs containing fairly short stretches of 2’O-methyl RNA 
between 15 bp duplex regions are able to bind two PKRs, but don’t activate. 
Interestingly, these RNAs induced dimerization. Dimer interface mutants R262D and 
Y323A were previously thought to be catalytically inactive due to their inability to 
dimerize17. However, we observed that both mutants dimerize upon dsRNA binding as 
well as in the absence of dsRNA. Our results reveal the presence of a novel inactive 
dimer species that may serve to regulate its activation when bound to a specific dsRNA 
ligand. Interestingly, the dsRNA structure can affect the nature of the dimer 
configuration.  A specific back-to-back dimer is critical for PKR activation.  
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PKR belongs to a family of eIF2α kinases. PERK60 (PKR-like endoplasmic 
reticulum kinase) and PKR exist as unphosphorylated monomers in solution. In the 
presence of an activating dsRNA they form the back-to-back dimer and become active. 
GCN2 62(general control non-derepressible 2) and HRI61 (heme-regulated inhibitor 
kinase) exist as constitutive inactive dimers in solution. However, a rearrangement of 
their dimer interface is required for activation.  Since the eIF2α kinases participate in a 
myriad of pathways that eventually lead to cell death, activation must be tightly 
regulated within the cell. Inactive dimer configurations may exist to lock the kinases and 
prevent any aberrant or background activation. High throughput transcriptional analysis 
show that human cells can produce hundred of dsRNA74. PKR-dsRNA binding is non-
sequence specific and under low salt conditions even short RNAs can bind more than 
one PKR13,59. Inactive PKR dimers may form to prevent inappropriate activation upon 
binding to host dsRNA ligands. The nature of the inactive dimer interface, however, 
remains elusive. Dimerization assays performed using a FRET pair at position 301 
instead of 261 demonstrate that PKR does not form a GCN2-like antiparallel inactive 
dimer interface.  Future experiments to probe the inactive dimer interface can involve 
the characterization of PKR constructs with FRET pairs at several different locations on 
the kinase dimer.  Alternately, high resolution structural analyses of catalytically inactive 
mutants R262D or Y323A mutants will likely answer the questions pertaining to the 
specific inactive dimer interface.   
Although PKR activation has been studied extensively, the precise mechanism of 
autophosphorylation is elusive since the active dimer is oriented such that the active site 
clefts are facing away from each other. Cis-phosphorylation of T446 has been 
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suggested as a likely first step in activation followed by the trans-autophosphorylation at 
multiple serine and threonine sites making the enzyme fully active65. To test the various 
binding interfaces of the kinase domains at different stages in activation a number of 
FRET pair containing constructs can be designed and assayed. For example, FRET 
pairs can be incorporated that show enhanced energy transfer when a front-to-back or 
front-to-front interface is formed.  
The isolation and high-resolution characterization of dimeric PKR species is 
challenging since they are interact weakly and reversibly in solution. The creation of 
constructs with strategically placed cysteine pairs can allow us to trap dimers via 
disulfide bonding, and purify them for biophysical or structural characterization.  
   PKR contains a ~90 residues interdomain linker. The N-terminal regions (169-
228) is variable in length across different orthologs and is absent in hamster PKR. The 
C-terminal end is shorter and is enriched in positively charged residues.  AFM56, NMR35 
and SAXS34 analysis show that PKR exists in ensemble of conformations likely due to 
the disorder in the linker. The linker also presents a challenge for the crystallization of 
the full-length enzyme.  To define the role of the linker we created linker-deleted 
constructs PKRΔV and PKRΔVB and functionally characterized them (Chapter 5). 
PKRΔV autophosphoryalates in the absence of dsRNA much more potently than WT 
PKR. In addition, it binds to 40 bp dsRNA with a higher stoichiometry than WT PKR. 
Overall, the construct is potently active since increased dsRNA binding stoichiometries 
are directly correlation with higher levels of activation. These results suggest that the 
long unstructured linker serves to negatively regulate PKR activation by curbing 
background autophosphorylation and limiting PKR assembly on dsRNAs.  L18 protein of 
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the 60 S ribosomal unit, which is overexpressed in patients with colorectal cancer 
sequesters PKR via the dsRNA binding domain and prevents it from activating89. This 
indicates that the cells likely employ several pathways to negatively regulate PKR 
activity.    
The linker-deleted constructs of PKR have thus far only been characterized with 
duplex RNAs. They may play a role in recognizing secondary structural elements of 
RNAs that exist and bind PKR in vivo. Further experiments can be conducted to 
characterize the role of the linker in recognition of structured RNAs or ss-dsRNAs. One 
of the most well studied consequences of PKR activation is eIF2α phosphorylation. 
However, PKR participates in several pathways involving cell differentiation, cell growth, 
heat shock stress, UV stress, bacterial infection, etc. It is possible that the linker may 
play a larger role in signaling and other downstream processes. 
Most dsRBD-containing proteins possess a single copy. The footprint of a dsRBD 
on a dsRNA is 16 bps. Yet, PKR, which has two such dsRBDs is able to bind 20 bp 
dsRNAs in a 2:1 stoichiometry. Interestingly, these dsRNAs do not induce activation. 
NMR20 and AUC analyses demonstrate that the inability to activate is due to the 
impaired dsRBD2 binding. We tested this model by mutating residues within the 
dsRBD2 that are predicted to bind dsRNA based on sequence and structural homology 
with Xlrbpa2 (Chapter 6). The quad mutant K150A, Q151A, H126A, N106A is able to 
bind PKR in a 2:1 stoichiometry but does not activate. These results suggest that 
specific contacts made between the dsRBD2 and dsRNA are essential for dsRNA-
induced PKR activation. Interestingly, the triple mutant K150A, Q151A, H126A is able to 
activate suggesting that N106A may play a key role in dsRNA-induced activation.  
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Ongoing experiments in the lab involve the functional characterization of N106A 
single mutant. More detailed chemical shift measurements also need to be performed 
with p20 WT and quad mutant constructs to ascertain if the mutations are blocking 
dsRBD2 binding.  
In summation, we have developed a reproducible and reliable FRET-based assay 
to measure dimerization of PKR upon dsRNA binding. This assay with can be used with 
virtually any ligand as long as the anisotropy differences elicited by depolarization are 
large enough and measurable. Our assays reveal a novel inactive dimer species, which 
may exist as a mechanism for PKR to distinguish host and viral dsRNAs. We have 
determined that the unstructured linker serves to negatively regulate PKR activation in 
the absence of an appropriate stimulus.  The role of the second dsRBD has also been 
explored. Mutation of residues predicted to lie within the dsRBD-dsRNA interface block 
PKR activation, but reduce dsRNA binding affinity by ~4 fold compared to WT PKR. 
These results suggest that a dsRBD2 mediated dsRNA binding may be key for 
activation, and that PKR may distinguish activating and non-activating dsRNAs based 
on the relative affinity of the dsRBD2.  
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